# EDGAR Filing Document

**Accession Number:** 0001487952
**File Stem:** 0001437749-25-032882
**Filing Date:** 2025-11
**Character Count:** 157444
**Document Hash:** aff80ea5a08bcb9350baa20cf28897bb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-032882.hdr.sgml**: 20251104

**ACCESSION NUMBER**: 0001437749-25-032882

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 82

**CONFORMED PERIOD OF REPORT**: 20250927

**FILED AS OF DATE**: 20251104

**DATE AS OF CHANGE**: 20251104

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vishay Precision Group, Inc.
- **CENTRAL INDEX KEY:** 0001487952
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRONIC COMPONENTS & ACCESSORIES [3670]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 270986328
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34679
- **FILM NUMBER:** 251446651

**BUSINESS ADDRESS:**
- **STREET 1:** 3 GREAT VALLEY PARKWAY, SUITE 150
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355
- **BUSINESS PHONE:** 484-321-5300

**MAIL ADDRESS:**
- **STREET 1:** 3 GREAT VALLEY PARKWAY, SUITE 150
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355

?xml version='1.0' encoding='ASCII'? vpg20250818_10q.htm

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>**September 27, 2025**</u>

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from _____ to _____**

**Commission File Number <u>1-34679</u>**

**VISHAY PRECISION GROUP, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **27-0986328** |
| (State or Other Jurisdiction of Incorporation) | (I.R.S. Employer Identification Number) |
| **3 Great Valley Parkway, Suite 150** |  |
| **Malvern, PA, 19355** | **484-321-5300** |
| (Address of Principal Executive Offices) (Zip Code) | (Registrant's Telephone Number, including area code) |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, $0.10 par value | VPG | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files. ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |  |

---

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of November 4, 2025, the registrant had 12,256,197 shares of its common stock and 1,022,887 shares of its Class B convertible common stock outstanding.

------

**VISHAY PRECISION GROUP, INC.**

**FORM 10-Q**

**September 27, 2025**

**CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | Page Number |
| **<u>PART I.</u>** | **<u>FINANCIAL INFORMATION</u>** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 1.</u> | [<u>Financial Statements</u>](#parti) |  |
|  | [<u>Consolidated Condensed Balance Sheets</u>](#parti)<br> – September 27, 2025 (Unaudited) and December 31, 2024 | <u>[3](#parti)</u> |
|  | [<u>Consolidated Condensed Statements of Operations</u>](#income)<br> (Unaudited) – Fiscal Quarters Ended September 27, 2025 and September 28, 2024 | <u>[5](#income)</u> |
|  | [<u>Consolidated Condensed Statements of Operations</u>](#incomeytd)<br> (Unaudited) – Nine Fiscal Months Ended September 27, 2025 and September 28, 2024 |  |
|  | [<u>Consolidated Condensed Statements of Comprehensive Income</u>](#compinc)<br> (Unaudited) – Fiscal Quarter Ended September 27, 2025 and September 28, 2024 | <u>[7](#compinc)</u> |
|  | [<u>Consolidated Condensed Statements of Comprehensive Income</u>](#compimcytd)<br> (Unaudited) – Nine Fiscal Months Ended September 27, 2025 and September 28, 2024 |  |
|  | [<u>Consolidated Condensed Statements of Cash Flows</u>](#cfs)<br> (Unaudited) – Nine Fiscal Months Ended September 27, 2025 and September 28, 2024 | <u>[9](#cfs)</u> |
|  | [<u>Consolidated Condensed Statements of Equity</u>](#equity)<br> (Unaudited) – Fiscal Quarter Ended September 27, 2025 and September 28, 2024 | <u>[10](#equity)</u> |
|  | [<u>Consolidated Condensed Statements of Equity</u>](#equityytd)<br> (Unaudited) – Nine Fiscal Months Ended September 27, 2025 and September 28, 2024 |  |
|  | [<u>Notes to Unaudited Consolidated Condensed Financial Statements</u>](#notes) | <u>[12](#notes)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 2.</u> | [<u>Management</u><u>'</u><u>s Discussion and Analysis of Financial Condition and Results of Operations</u>](#mda) | <u>[24](#mda)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 3.</u> | [<u>Quantitative and Qualitative Disclosures About Market Risk</u>](#qqdmr) | <u>[37](#qqdmr)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 4.</u> | [<u>Controls and Procedures</u>](#cps) | <u>[37](#cps)</u> |
| **<u>PART II.</u>** | [**<u>OTHER INFORMATION</u>**](#partii) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 1.</u> | [<u>Legal Proceedings</u>](#legal) | <u>[38](#legal)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 1A.</u> | [<u>Risk Factors</u>](#risks) | <u>[38](#risks)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 2.</u> | [<u>Unregistered Sales of Equity Securities and Use of Proceeds</u>](#uses) | <u>[38](#uses)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 3.</u> | [<u>Defaults Upon Senior Securities</u>](#duss) | <u>[38](#duss)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 4.</u> | [<u>Mine Safety Disclosures</u>](#msd) | <u>[38](#msd)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 5.</u> | [<u>Other Information</u>](#otherinfo) | <u>[38](#otherinfo)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Item 6.</u> | [<u>Exhibits</u>](#exhibits) | <u>[39](#exhibits)</u> |
|  | [**<u>SIGNATURES</u>**](#sigs) | <u>[40](#sigs)</u> |

---

------

**PART I - FINANCIAL INFORMATION**

**<u>Item 1.</u> <u>FINANCIAL STATEMENTS</u>**

**VISHAY PRECISION GROUP, INC.**<br> Consolidated Condensed Balance Sheets<br> *(In thousands)*<br>

---

| | | |
|:---|:---|:---|
|  | ***September 27, 2025*** | ***December 31, 2024*** |
|  | *(Unaudited)* |  |
| **Assets** |  |  |
| Current assets: |  |  |
| Cash and cash equivalents | $**86253** | $79272 |
| Accounts receivable, net | **59608** | 51200 |
| Inventories: |  |  |
| Raw materials | **32544** | 33013 |
| Work in process | **28900** | 27187 |
| Finished goods | **24519** | 23960 |
| Inventories, net | **85963** | 84160 |
| Prepaid expenses and other current assets | **20514** | 17088 |
| Asset held for sale | **—** | 5229 |
| Total current assets | **252338** | 236949 |
| Property and equipment: |  |  |
| Land | **2387** | 2316 |
| Buildings and improvements | **78535** | 68125 |
| Machinery and equipment | **136393** | 132938 |
| Software | **11497** | 10351 |
| Construction in progress | **3471** | 11246 |
| Accumulated depreciation | **(155715)** | (145475) |
| Property and equipment, net | **76568** | 79501 |
| Goodwill | **47270** | 46819 |
| Intangible assets, net | **39156** | 41815 |
| Operating lease right-of-use assets | **22768** | 24316 |
| Other assets | **24220** | 21535 |
| Total assets | $**462320** | $450935 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -3-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Balance Sheets

*(In thousands)*

---

| | | |
|:---|:---|:---|
|  | ***September 27, 2025*** | ***December 31, 2024*** |
|  | *(Unaudited)* |  |
| **Liabilities and equity** |  |  |
| Current liabilities: |  |  |
| Trade accounts payable | $**10788** | $9890 |
| Payroll and related expenses | **19736** | 18546 |
| Other accrued expenses | **24159** | 19725 |
| Income taxes | **2604** | 880 |
| Current portion of operating lease liabilities | **4212** | 3998 |
| Total current liabilities | **61499** | 53039 |
| Long-term debt | **20555** | 31441 |
| Deferred income taxes | **2551** | 3779 |
| Operating lease liabilities | **19065** | 19928 |
| Other liabilities | **14120** | 14193 |
| Accrued pension and other postretirement costs | **6726** | 6695 |
| Total liabilities | **124516** | 129075 |
| Equity: |  |  |
| Common stock, par value $0.10 per share: 25,000,000 shares authorized; 12,256,197 shares outstanding as of September 27, 2025 and 12,215,668 shares outstanding as of December 31, 2024 | **1340** | 1336 |
| Class B convertible common stock, par value $0.10 per share: 3,000,000 shares authorized; 1,022,887 shares outstanding as of September 27, 2025 and December 31, 2024 | **103** | 103 |
| Treasury stock, at cost - 1,137,995 shares held at September 27, 2025 and December 31, 2024 | **(25335)** | (25335) |
| Capital in excess of par value | **204029** | 202783 |
| Retained earnings | **199141** | 191977 |
| Accumulated other comprehensive loss | **(41520)** | (48897) |
| Total Vishay Precision Group, Inc. stockholders' equity | **337758** | 321967 |
| Noncontrolling interests | **46** | (107) |
| Total equity | **337804** | 321860 |
| Total liabilities and equity | $**462320** | $450935 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -4-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Operations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*(Unaudited - In thousands, except per share amounts)*

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** |
| Net revenues | $**79728** | $75727 |
| Costs of products sold | **47603** | 45467 |
| Gross profit | **32125** | 30260 |
| Selling, general and administrative expenses | **27296** | 26337 |
| Gain on asset held for sale | **(5544)** |  |
| Restructuring costs | **214** | 82 |
| Operating income | **10159** | 3841 |
| Other (expense) income : |  |  |
| Interest expense | **(425)** | (648) |
| Other | **159** | (2646) |
| Other expense | **(266)** | (3294) |
| Income before taxes | **9893** | 546 |
| Income tax expense | **1961** | 1874 |
| Net earnings (loss) | **7932** | (1328) |
| Less: net earnings attributable to noncontrolling interests | **74** | 23 |
| Net earnings (loss) attributable to VPG stockholders | $**7858** | $(1351) |
| Basic earnings (loss) per share attributable to VPG stockholders | $**0.59** | $(0.10) |
| Diluted earnings (loss) per share attributable to VPG stockholders | $**0.59** | $(0.10) |
| Weighted average shares outstanding - basic | **13279** | 13254 |
| Weighted average shares outstanding - diluted | **13344** | 13254 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -5-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Operations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*(Unaudited - In thousands, except per share amounts)*

---

| | | |
|:---|:---|:---|
|  | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** |
| Net revenues | $**226630** | $233869 |
| Costs of products sold | **136866** | 136108 |
| Gross profit | **89764** | 97761 |
| Selling, general and administrative expenses | **81708** | 80232 |
| Gain on asset held for sale | **(5544)** |  |
| Restructuring costs | **793** | 864 |
| Operating income | **12807** | 16665 |
| Other (expense) income : |  |  |
| Interest expense | **(1525)** | (1925) |
| Other | **(1781)** | 915 |
| Other expense | **(3306)** | (1010) |
| Income before taxes | **9501** | 15654 |
| Income tax expense | **2220** | 6508 |
| Net earnings | **7281** | 9146 |
| Less: net earnings attributable to noncontrolling interests | **117** | 3 |
| Net earnings attributable to VPG stockholders | $**7164** | $9143 |
| Basic earnings per share attributable to VPG stockholders | $**0.54** | $0.68 |
| Diluted earnings per share attributable to VPG stockholders | $**0.54** | $0.68 |
| Weighted average shares outstanding - basic | **13260** | 13367 |
| Weighted average shares outstanding - diluted | **13307** | 13405 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -6-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Comprehensive Income

*(Unaudited - In thousands)*

---

| | | |
|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** |
| Net earnings (loss) | $**7932** | $(1328) |
| Other comprehensive (loss) income, net of tax: |  |  |
| Foreign currency translation adjustment | **(1806**) | 6809 |
| Pension and other postretirement actuarial items | **2** | (8) |
| Other comprehensive (loss) income | **(1804**) | 6801 |
| Comprehensive income | **6128** | 5473 |
| Less: comprehensive income attributable to noncontrolling interests | **74** | 23 |
| Comprehensive income attributable to VPG stockholders | $**6054** | $5450 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -7-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Comprehensive Income

*(Unaudited - In thousands)*

---

| | | |
|:---|:---|:---|
|  | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** |
| Net earnings | $**7281** | $9146 |
| Other comprehensive income (loss), net of tax: |  |  |
| Foreign currency translation adjustment | **7363** | (679) |
| Pension and other postretirement actuarial items | **14** | (16) |
| Other comprehensive income (loss) | **7377** | (695) |
| Comprehensive income | **14658** | 8451 |
| Less: comprehensive income attributable to noncontrolling interests | **117** | 3 |
| Comprehensive income attributable to VPG stockholders | $**14541** | $8448 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -8-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Cash Flows

*(Unaudited - In thousands)*

---

| | | |
|:---|:---|:---|
|  | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** |
| **Operating activities** |  |  |
| Net earnings | $**7281** | $9146 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: |  |  |
| Depreciation and amortization | **11878** | 11771 |
| Loss (gain) on sale of property and equipment | **64** | (154) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gain on asset held for sale | **(5544)** |  |
| Share-based compensation expense | **1550** | 1060 |
| Inventory write-offs for obsolescence | **2334** | 1722 |
| Deferred (expense) income taxes | **(2322)** | 512 |
| Foreign currency impacts and other items | **270** | (1213) |
| Net changes in operating assets and liabilities: |  |  |
| Accounts receivable | **(6223**) | 3340 |
| Inventories | **(2084)** | (1816) |
| Prepaid expenses and other current assets | **(2863)** | (5576) |
| Trade accounts payable | **323** | (743) |
| Other current liabilities | **6499** | (3921) |
| Other non current assets and liabilities, net | **(1335)** | (767) |
| Accrued pension and other postretirement costs, net | **126** | (322) |
| Net cash provided by operating activities | **9954** | 13039 |
| **Investing activities** |  |  |
| Capital expenditures | **(4953)** | (6965) |
| Proceeds from sale of asset held for sale and property and equipment | **10891** | 647 |
| Net cash provided by (used in) investing activities | **5938** | (6318) |
| **Financing activities** |  |  |
| Repayments on revolving facility | **(11000)** |  |
| Debt issuance costs |  | (569) |
| Purchase of treasury stock |  | (7815) |
| Contributions (distributions) from noncontrolling interests | **36** | (50) |
| Payments of employee taxes on certain share-based arrangements | **(256)** | (860) |
| Net cash used in financing activities | **(11220)** | (9294) |
| Effect of exchange rate changes on cash and cash equivalents | **2309** | (315) |
| Increase (Decrease) in cash and cash equivalents | **6981** | (2888) |
| Cash and cash equivalents at beginning of period | **79272** | 83965 |
| Cash and cash equivalents at end of period | $**86253** | $81077 |
| **Supplemental disclosure of investing transactions:** |  |  |
| Capital expenditures accrued but not yet paid | **1239** | $1354 |
| **Supplemental disclosure of financing transactions:** |  |  |
| Excise tax on net share repurchases accrued but not yet paid |  | 60 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -9-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Equity

*(Unaudited - In thousands, except share amounts)*

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***September 27, 2025*** | ***September 27, 2025*** | ***September 27, 2025*** | ***September 27, 2025*** | ***September 27, 2025*** | ***September 27, 2025*** | ***September 27, 2025*** | ***September 27, 2025*** | ***September 27, 2025*** |
|  |  | ***Class B*** |  |  |  | ***Accumulated*** |  |  |  |
|  |  | ***Convertible*** |  | ***Capital in*** |  | ***Other*** | ***Total VPG Inc.*** |  |  |
|  | ***Common*** | ***Common*** | ***Treasury*** | ***Excess of*** | ***Retained*** | ***Comprehensive*** | ***Stockholders'*** | ***Noncontrolling*** | ***Total*** |
|  | ***Stock*** | ***Stock*** | ***Stock*** | ***Par Value*** | ***Earnings*** | ***Income (Loss)*** | ***Equity*** | ***Interests*** | ***Equity*** |
| Balance at June 28, 2025 | $**1339** | $**103** | $**(25335)** | $**203537** | $**191283** | $**(39716)** | $**331211** | $**44** | $**331255** |
| Net earnings | **—** | **—** | **—** |  | **7858** |  | **7858** | **74** | **7932** |
| Other comprehensive income | **—** | **—** | **—** |  |  | **(1804**) | **(1804**) |  | **(1804**) |
| Share-based compensation expense | **—** | **—** | **—** | **493** |  |  | **493** |  | **493** |
| Restricted stock issuances (3,065 shares) | **1** | **—** | **—** | **(1)** |  |  | **(0)** |  | **(0)** |
| Distributions to noncontrolling interests | **—** | **—** | **—** |  |  |  |  | **(72)** | **(72**) |
| Balance at September 27, 2025 | $**1340** | $**103** | $**(25335)** | $**204029** | $**199141** | $**(41520)** | $**337758** | $**46** | $**337804** |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***September 28, 2024*** | ***September 28, 2024*** | ***September 28, 2024*** | ***September 28, 2024*** | ***September 28, 2024*** | ***September 28, 2024*** | ***September 28, 2024*** | ***September 28, 2024*** | ***September 28, 2024*** |
|  |  | ***Class B*** |  |  |  | ***Accumulated*** |  |  |  |
|  |  | ***Convertible*** |  | ***Capital in*** |  | ***Other*** | ***Total VPG Inc.*** |  |  |
|  | ***Common*** | ***Common*** | ***Treasury*** | ***Excess of*** | ***Retained*** | ***Comprehensive*** | ***Stockholders'*** | ***Noncontrolling*** | ***Total*** |
|  | ***Stock*** | ***Stock*** | ***Stock*** | ***Par Value*** | ***Earnings*** | ***Income (Loss)*** | ***Equity*** | ***Interests*** | ***Equity*** |
| Balance at June 29, 2024 | $1336 | $103 | $(23388) | $202765 | $192560 | $(46365) | $327011 | $23 | $327034 |
| Net loss |  |  |  |  | (1351) |  | (1351) | 23 | (1328) |
| Other comprehensive loss |  |  |  |  |  | 6801 | 6801 |  | 6801 |
| Share-based compensation expense |  |  |  | 107 |  |  | 107 |  | 107 |
| Purchase of treasury stock. (63,227 shares) |  |  | (1928) |  |  |  | (1928) |  | (1928) |
| Excise tax on net share repurchase |  |  | (19) |  |  |  | (19) |  | (19) |
| Distributions to noncontrolling interests |  |  |  |  |  |  |  | (10) | (10) |
| Balance at September 28, 2024 | $**1336** | $**103** | $**(25335)** | $**202872** | $**191209** | $**(39564)** | $**330621** | $**36** | $**330657** |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -10-

------

**VISHAY PRECISION GROUP, INC.**

Consolidated Condensed Statements of Equity

*(Unaudited - In thousands, except share amounts)*

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** |
|  |  | ***Class B*** |  |  |  | ***Accumulated*** |  |  |  |
|  |  | ***Convertible*** |  | ***Capital in*** |  | ***Other*** | ***Total VPG Inc.*** |  |  |
|  | ***Common*** | ***Common*** | ***Treasury*** | ***Excess of*** | ***Retained*** | ***Comprehensive*** | ***Stockholders'*** | ***Noncontrolling*** | ***Total*** |
|  | ***Stock*** | ***Stock*** | ***Stock*** | ***Par Value*** | ***Earnings*** | ***Income (Loss)*** | ***Equity*** | ***Interests*** | ***Equity*** |
| Balance at December 31, 2024 | $**1336** | $**103** | $**(25335)** | $**202783** | $**191977** | $**(48897)** | $**321967** | $**(107)** | $**321860** |
| Net earnings |  |  |  |  | **7164** |  | **7164** | **117** | **7281** |
| Other comprehensive income |  |  |  |  |  | **7377** | **7377** |  | **7377** |
| Share-based compensation expense |  |  |  | **1550** |  |  | **1550** |  | **1550** |
| Restricted stock issuances (40,529 shares) | **4** |  |  | **(304)** |  |  | **(300)** |  | **(300)** |
| Excise tax on net share repurchase |  |  |  |  |  |  |  |  |  |
| Contributions from noncontrolling interests |  |  |  |  |  |  |  | **36** | **36** |
| Balance at September 27, 2025 | $**1340** | $**103** | $**(25335)** | $**204029** | $**199141** | $**(41520)** | $**337758** | $**46** | $**337804** |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** |
|  |  | ***Class B*** |  |  |  | ***Accumulated*** |  |  |  |
|  |  | ***Convertible*** |  | ***Capital in*** |  | ***Other*** | ***Total VPG Inc.*** |  |  |
|  | ***Common*** | ***Common*** | ***Treasury*** | ***Excess of*** | ***Retained*** | ***Comprehensive*** | ***Stockholders'*** | ***Noncontrolling*** | ***Total*** |
|  | ***Stock*** | ***Stock*** | ***Stock*** | ***Par Value*** | ***Earnings*** | ***Income (Loss)*** | ***Equity*** | ***Interests*** | ***Equity*** |
| Balance at December 31, 2023 | $1330 | $103 | $(17460) | $202672 | $182066 | $(38869) | $329842 | $83 | $329925 |
| Net earnings |  |  |  |  | 9143 |  | 9143 | 3 | 9146 |
| Other comprehensive loss |  |  |  |  |  | (695) | (695) |  | (695) |
| Share-based compensation expense |  |  |  | 1060 |  |  | 1060 |  | 1060 |
| Restricted stock issuances (55,219 shares) | 6 |  |  | (860) |  |  | (854) |  | (854) |
| Purchase of treasury stock (244,702 shares) |  |  | (7815) |  |  |  | (7815) |  | (7815) |
| Excise tax on net share repurchase |  |  | (60) |  |  |  | (60) |  | (60) |
| Distributions to noncontrolling interests |  |  |  |  |  |  |  | (50) | (50) |
| Balance at September 28, 2024 | $1336 | $103 | $(25335) | $202872 | $191209 | $(39564) | $330621 | $36 | $330657 |

---

***See accompanying notes.***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -11-

------

**Vishay Precision Group, Inc.**

***Notes to Unaudited Consolidated Condensed Financial Statements***

**Note *1*** – **Basis of Presentation**

***Background***

Vishay Precision Group, Inc. ("VPG" or the "Company") is a global leader in precision measurement and sensing technologies that help power the future by bridging the physical world with the digital one. Many of our specialized sensors, weighing solutions, and measurement systems are "designed-in" by our customers, and address growing applications across a diverse array of industries and markets. Our products are marketed under brand names that we believe are characterized as having a very high level of precision and quality, and we employ an operationally diversified structure to manage our businesses.

***Interim Financial Statements***

These unaudited consolidated condensed financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial statements and therefore do *not* include all information and footnotes necessary for the presentation of financial position, results of operations, and cash flows required by accounting principles generally accepted in the United States for complete financial statements. The information furnished reflects all normal recurring adjustments which are, in the opinion of management, necessary for a fair summary of the financial position, results of operations, and cash flows for the interim periods presented. These consolidated condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto as of *December 31, 2024* and *2023* and for each of the *three* years in the period ended *December 31, 2024*, included in VPG's Annual Report on Form *10*-K for the fiscal year ended *December 31, 2024*, filed with the SEC on *February 25, 2025.* The results of operations for the fiscal quarter ended *September 27, 2025* are *not* necessarily indicative of the results to be expected for the full year. VPG reports interim financial information for *13*-week periods beginning on a Sunday and ending on a Saturday, except for the *first* quarter, which always begins on *January 1,* and the *fourth* quarter, which always ends on *December 31.* The *four* fiscal quarters in *2025* and *2024* end on the following dates:

---

| | | |
|:---|:---|:---|
|  | ***2025*** | ***2024*** |
| Quarter *1* | *March 29,* | *March 30,* |
| Quarter *2* | *June 28,* | *June 29,* |
| Quarter *3* | *September 27,* | *September 28,* |
| Quarter *4* | *December 31,* | *December 31,* |

---

***Recent Accounting Pronouncements***

The Company evaluates the applicability and impact of all Accounting Standards Updates ("ASUs") issued by the Financial Accounting Standards Board ("FASB").

In *November 2023,* the FASB issued ASU *2023*-*07,* Segment Reporting (Topic *280*): Improvements to Reportable Segment Disclosures. The ASU expands public entities' segment disclosures by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment's profit or loss and assets. The ASU also allows, in addition to the measure that is most consistent with U.S. GAAP, the disclosure of additional measures of segment profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources. The ASU is effective for the Company's Annual Report on Form *10*-K for the fiscal year ended *December 31, 2024*, and subsequent interim periods, with early adoption permitted. As part of the Annual Report for the year ended *December 31, 2024*, which was filed on *February 25, 2025,* the Company adopted ASU *2023*-*07,* which was applied retrospectively to all prior periods presented. Refer to Note *14* herein for further details regarding this adoption.

In *December 2023,* the FASB issued ASU *No. 2023*-*09,* Income Taxes (Topic *740*): Improvements to Income Tax Disclosures. This ASU requires disclosure of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The amendment also includes other changes to improve the effectiveness of income tax disclosures, including further disaggregation of income taxes paid for individually significant jurisdictions. This ASU is effective for annual periods beginning after *December 15, 2024.* Early adoption is permitted. Adoption of this ASU should be applied on a prospective basis, although retrospective application is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

In *November 2024,* the FASB issued ASU *No. 2024*-*03,* Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic *220*-*40*), Disaggregation of Income Statement Expenses. This update aims to enhance the transparency of financial reporting by requiring public business entities (PBEs) to provide disaggregated disclosure of certain income statement expense captions into specified categories in disclosures within the footnotes to the financial statements. The ASU is effective for annual fiscal years beginning after *December 15, 2026,* and interim periods within fiscal years beginning after *December 15, 2027.* Early adoption is permitted. Adoption of this ASU should be applied on a prospective basis, although retrospective application is permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *12*-

------

**<u>Note *2*</u>** <u>–</u> **<u>Revenues</u>**

***Revenue Recognition***

The following table disaggregates net revenue by geographic region from contracts with customers based on net revenues generated by subsidiaries within that geographic location *(in thousands)*:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***September 27, 2025*** | ***September 27, 2025*** | ***September 27, 2025*** | ***September 27, 2025*** | ***September 28, 2024*** | ***September 28, 2024*** | ***September 28, 2024*** | ***September 28, 2024*** |
|  | ***Sensors*** | ***Weighing Solutions*** | ***Measurement Systems*** | ***Total*** | ***Sensors*** | ***Weighing Solutions*** | ***Measurement Systems*** | ***Total*** |
| United States | $**13685** | $**11665** | $**10581** | $**35931** | $10068 | $11154 | $14751 | $35973 |
| Europe | **8363** | **12778** | **3371** | $**24512** | 7475 | 11017 | 378 | 18870 |
| Asia | **5492** | **3043** | **2683** | $**11218** | 5479 | 2901 | 1778 | 10158 |
| Canada |  | **—** | **3931** | $**3931** |  |  | 5445 | 5445 |
| Israel | **4085** | **51** |  | $**4136** | 5179 | 102 |  | 5281 |
| Total | $**31625** | $**27537** | $**20566** | $**79728** | $28201 | $25174 | $22352 | $75727 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 27, 2025*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** | ***Nine Fiscal Months Ended September 28, 2024*** |
|  | ***Sensors*** | ***Weighing Solutions*** | ***Measurement Systems*** | ***Total*** | ***Sensors*** | ***Weighing Solutions*** | ***Measurement Systems*** | ***Total*** |
| United States | $**34918** | $**35320** | $**35576** | $**105814** | $29931 | $33491 | $39204 | $102626 |
| Europe | $**23879** | $**38690** | $**4561** | $**67130** | 24936 | 38489 | 3539 | 66964 |
| Asia | $**15400** | $**9240** | $**6521** | $**31161** | 16378 | 9119 | 6873 | 32370 |
| Canada | $— | $**22** | $**11325** | $**11347** |  | 101 | 16303 | 16404 |
| Israel | $**11046** | $**132** | $— | $**11178** | 15238 | 267 |  | 15505 |
| Total | $**85243** | $**83404** | $**57983** | $**226630** | $86483 | $81467 | $65919 | $233869 |

---

The following table disaggregates net revenue from contracts with customers by market sector *(in thousands)*.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** | ***September 27, 2025*** | ***September 28, 2024*** |
| Test & Measurement | $**16829** | $14337 | $**46442** | $43955 |
| Avionics, Military & Space | **7262** | 8581 | **19918** | 21769 |
| Transportation | **14724** | 12802 | **45651** | 38985 |
| Other Markets | **14352** | 14826 | **42415** | 48750 |
| Industrial Weighing | **9083** | 8578 | **26742** | 28021 |
| General Industrial | **5720** | 4538 | **15326** | 14702 |
| Steel | **11758** | 12065 | **30136** | 37687 |
| Total | $**79728** | $75727 | $**226630** | $233869 |

---

***Contract Assets & Liabilities***

Contract assets are established when revenues are recognized prior to a contractual payment due from the customer. When a payment becomes due based on the contract terms, the Company will reduce the contract asset and record a receivable. Contract liabilities are deferred revenues that are recorded when cash payments are received or due in advance of our performance obligations. Our payment terms vary by the type and location of the products offered. The term between invoicing and when payment is due is *not* significant.

The outstanding contract assets and liability accounts were as follows *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***Contract Asset*** | ***Contract Liability*** |
|  |  | ***Accrued*** |
|  | ***Unbilled*** | ***Customer*** |
|  | ***Revenue*** | ***Advances*** |
| Balance at December 31, 2024 | $3330 | $8272 |
| Balance at September 27, 2025 | 2563 | 8893 |
| Increase (decrease) | $(767) | $621 |

---

The amount of revenue recognized during the *nine* fiscal months ended *September 27, 2025* that was included in the contract liability balance at *December 31, 2024* was $5.9 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *13*-

------

**<u>Note *3*</u>** <u>–</u> **<u>Sale Asset Held for Sale</u>**

***Sale of Manufacturing Facility in Kent, Washington***

On *July 10, 2025,* as part of the Company's ongoing strategy to focus on its core operations and optimize its asset base utilization, the Company completed the sale of its manufacturing facility located at Kent, Washington which was part of the Weighing Solutions Segment.

The total sale proceeds amounted to $11.5 million, and the net proceeds, after deducting broker's commission and real estate excise tax, were approximately $10.8 million.

The carrying amount of the asset was previously classified as asset held for sale under current assets in the consolidated balance sheet as of *December 31, 2024* after meeting the criteria outlined in ASC *360. No* further depreciation was recorded once the asset was classified as held for sale.

Upon completion of the sale, the Company recognized a gain of approximately $5.5 million in *July 2025,* which is included in Operating income in the condensed consolidated statements of operations for the quarter ended and *nine* fiscal months ended *September 27, 2025.*

The net cash proceeds were used to repay a portion of the Company's credit facility, as further discussed in *Note *7* – Long-Term Debt*.

**<u>Note *4*</u>** <u>–</u> **<u>Goodwill</u>**

The Company tests the goodwill in each of its goodwill reporting units for impairment at least annually, as of the *first* day of its *fourth* quarter, and whenever events or changes in circumstances occur indicating that a possible impairment *may* have been incurred.

The change in the carrying amount of goodwill by reporting unit is as follows *(in thousands)*:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Total** | **Measurement Systems** | **Measurement Systems** | **Measurement Systems** | **Measurement Systems** | **Weighing Solutions** |
|  | | *Steel* | *Nokra* | *DSI* | *DTS* | *On-board weighing* |
| Balance at December 31, 2024 | $46819 | $5964 | $1633 | $16878 | $16033 | $6311 |
| Adjustment <sup>(1)</sup> | $— | $1633 | $(1633) | $— | $— | $— |
| Foreign currency translation adjustment | $451 | $406 | $— | $45 | $— | $— |
| Balance at September 27, 2025 | $47270 | $8003 | $— | $16923 | $16033 | $6311 |

---

<sup>(*1*)</sup> The goodwill resulting from the acquisition of Nokra in *September 2024,* was allocated to the Steel reporting unit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *14*-

------

**<u>Note *5*</u>** <u>–</u> **<u>Leases</u>**

The Company primarily leases office and manufacturing facilities in addition to vehicles, which have remaining terms ranging from less than one year to eleven years, *four* months.

The Company has *no* finance leases.

Leases recorded on the balance sheet consist of the following *(in thousands)*:

---

| | | |
|:---|:---|:---|
| **Leases** | ***September 27, 2025*** | ***December 31, 2024*** |
| **Assets** |  |  |
| Operating lease right of use asset | $**22768** | $24316 |
| **Liabilities** |  |  |
| Operating lease - current | $**4212** | $3998 |
| Operating lease - non-current | $**19065** | $19928 |

---

Other information related to lease term and discount rate is as follows:

---

| | |
|:---|:---|
|  | ***September 27, 2025*** |
| Operating leases weighted average remaining lease term (in years) | 6.44 |
| Operating leases weighted average discount rate | 4.97% |

---

The components of lease expense are as follows *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** | ***September 27, 2025*** | ***September 28, 2024*** |
| Operating lease cost | $**1373** | $1319 | $**4048** | $4024 |
| Short-term lease cost | **46** | 6 | **82** | 31 |
| Sublease income | **(139)** | (111) | **(387)** | (334) |
| Total net lease cost | $**1280** | $1214 | $**3743** | $3721 |

---

Right of use assets obtained in exchange for new operating lease liability during the *nine* fiscal months ended *September 27, 2025* were $1.3 million. The Company paid $4.0 million and $3.9 million for its operating leases for each of the *nine* fiscal months ended *September 27, 2025* and *September 28, 2024*, which are included in operating cash flows on the consolidated condensed statements of cash flows.

Undiscounted maturities of operating lease payments as of *September 27, 2025* are summarized as follows *(in thousands)*:

---

| | |
|:---|:---|
| 2025 | $**1400** |
| 2026 | **4714** |
| 2027 | **4154** |
| 2028 | **3823** |
| 2029 | **3685** |
| Thereafter | **9312** |
| Total future minimum lease payments | $**27088** |
| Less: amount representing interest | **(3811**) |
| Present value of future minimum lease payments | $**23277** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *15*-

------

**<u>Note *6*</u>** <u>–</u> **<u>Income Taxes</u>**

The Company reported an effective income tax rate of 19.8% for the *third* fiscal quarter of *2025,* compared to 343.2% in the *third* fiscal quarter of *2024.*

The effective tax rate for the fiscal quarter ended *September 27, 2025,* primarily resulted from an increase in U.S. taxable income, the impact of the One Big Beautiful Bill Act (the "OBBBA"), and changes in the valuation allowance on deferred tax assets, which provided a tax benefit. Sequentially, the effective tax rate for the *third* quarter was mainly influenced by foreign income taxed at varying statutory rates and changes in the valuation allowance on deferred tax assets. For the *nine* fiscal months ended *September 27, 2025,* the Company reported an effective tax rate of 23.4%, compared to 41.6% for the same period in *2024.*

The year-over-year change in the effective tax rate was primarily driven by a reduction in the valuation allowance on certain deferred tax assets and the impact of foreign currency exchange rate fluctuations on the tax provisions of our non-U.S. entities.

On *July 4, 2025,* the OBBBA was enacted into law, extending key provisions of the *2017* Tax Cuts and Jobs Act. The OBBBA restores expensing of domestic research expenditures for years beginning after *December 31, 2024.* Additionally, the OBBBA restores the EBITDA-based interest expense limitation and includes changes related to the U.S. taxation of the income of our foreign subsidiaries and certain foreign derived income, and the base erosion and anti-abuse tax, and provides for accelerated depreciation for property acquired and placed in service after *January 19, 2025.* The legislation has multiple effective dates, with certain provisions effective in *2025* and others implemented through *2027.* Due to the OBBBA provisions, the Company recorded tax benefit for the quarter as a decrease in valuation allowance on part of our deferred tax assets.

The Company and its subsidiaries are subject to income taxes imposed by the U.S., various states, and the foreign jurisdictions in which we operate. Each jurisdiction establishes rules that set forth the years which are subject to examination by its tax authorities. While the Company believes the tax positions taken on its tax returns for each jurisdiction are supportable, they *may* still be challenged by the jurisdiction's tax authorities. In anticipation of such challenges, the Company has established reserves for tax-related uncertainties. These liabilities are based on the Company's best estimate of the potential tax exposures in each respective jurisdiction. It *may* take a number of years for a final tax liability in a jurisdiction to be determined, particularly in the event of an audit. If an uncertain matter is determined favorably, there could be a reduction in the Company's tax expense. An unfavorable determination could increase tax expense and could require a cash payment, including interest and penalties.

**<u>Note *7*</u>** <u>–</u> **<u>Long-Term Debt</u>**

Long-term debt consists of the following *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***September 27, 2025*** | ***December 31, 2024*** |
| Credit Agreement - Revolving Facility | $**32000** | $32000 |
| Repayment of credit facility | **(11000)** |  |
| Deferred financing costs | **(445)** | (559) |
| Total long-term debt | $**20555** | $31441 |

---

***2024* Credit Agreement***

On *August 15, 2024,* the Company entered into a Fourth Amended and Restated Credit Agreement (the *"2024* Credit Agreement") among the Company, the lenders party thereto, JPMorgan Chase Bank, N.A., Wells Fargo Bank, N.A. and HSBC as joint lead arrangers and joint bookrunner, and JPMorgan Chase Bank, N.A., as agent for such lenders, pursuant to which its previously existing credit agreement, was amended and restated to, among other things, extend the maturity date from *March 20, 2025* to *August 15, 2029* and adjust the interest rate and commitment fee. The *2024* Credit Agreement provides for a multi-currency, secured credit facility (the *"2024* Revolving Facility") in an aggregate principal amount of $75.0 million, with a sublimit of $10 million which can be used for letters of credit for the account of the Company or its subsidiaries that are parties to the *2024* Credit Agreement, the proceeds of which *may* be used for working capital and general corporate purposes, and a portion of which were used to refinance the existing credit facility. The aggregate principal amount of the *2024* Revolving Facility *may* be increased by a maximum of $25.0 million upon the request of the Company, subject to the terms of the *2024* Credit Agreement. The Company *may* elect to make loans under the *2024* Revolving Facility in US Dollars, Euros, Canadian Dollars, Sterling, Japanese Yen or such other freely convertible foreign currency.

Amounts borrowed under the *2024* Revolving Facility accrue interest in an amount equal to a floating rate plus a specified margin. Such floating rates are (i) for loans denominated in US Dollars, at the Company's option, either (a) the greatest of: the Agent's prime rate, the Federal Funds rate, or a 1% floor (the "US Base Rate"), or (b) the SOFR, (ii) for loans denominated in Canadian Dollars, at the Company's option, either (*x*) the greatest of: the PRIMCAN Index rate, the average *30* day rate for loans accruing interest based on the Canadian Overnight Repo Rate Average ("CORRA") (the "Canadian Base Rate"), or (y) CORRA, (iii) for loans denominated in Pounds Sterling, the Sterling Overnight Index Average ("SONIA"), (iv) for loans denominated in Euros, the Euro Interbank Offered Rate ("EURIBOR"), and (v) for loans denominated in Japanese Yen, the Tokyo Interbank Offered Rate ("TIBOR"). The specified interest margin for US Base Rate Loans and Canadian Base Rate Loans is 0.25%. Depending upon the Company's leverage ratio, the interest rate margin for loans based on SOFR, CORRA, SONIA, EURIBOR and TIBOR ranges from 1.75% to 3.00% per annum. The Company is required to pay a quarterly fee of 0.20% per annum to 0.40% per annum on the unused portion of the *2024* Revolving Facility, which is also determined based on the Company's leverage ratio. Additional customary fees apply with respect to letters of credit.

On *July 17, 2025,* the Company made a partial repayment of its revolving debt in the amount of $11.0 million, using proceeds from the sale of manufacturing facility (see *Note *3* - Sale of *As*set Held for Sale*).

The repayment was made in accordance with the terms of the Credit Agreement and resulted in a corresponding reduction in the outstanding balance under the revolving credit facility. As of *September 27, 2025*, the outstanding balance under the revolving credit facility was $21.0 million, bearing interest at variable rates based on the Credit Agreement.

The obligations of the Company under the *2024* Credit Agreement are secured by pledges of stock in certain domestic and foreign subsidiaries, as well as guarantees by substantially all of the Company's domestic subsidiaries. The obligations of the Company and the guarantors under the *2024* Credit Agreement are secured by substantially all the assets (excluding real estate) of the Company and such guarantors. The *2024* Credit Agreement restricts the Company from paying cash dividends and requires the Company to comply with other customary covenants, representations, and warranties, including the maintenance of specific financial ratios. The financial maintenance covenants include an interest coverage ratio and a leverage ratio. The Company was in compliance with its financial maintenance covenants as of *September 27, 2025*. If the Company is *not* in compliance with any of these covenant restrictions, the *2024* Revolving Facility could be terminated by the lenders, and all amounts outstanding pursuant to the *2024* Revolving Facility could become immediately payable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *16*-

------

**<u>Note *8*</u>** <u>–</u> **<u>Accumulated Other Comprehensive (Loss) Income</u>**

The components of accumulated other comprehensive (loss) income net of tax, consist of the following *(in thousands)*:

---

| | | | |
|:---|:---|:---|:---|
|  | ***Foreign*** | ***Pension*** |  |
|  | ***Currency*** | ***and Other*** |  |
|  | ***Translation*** | ***Postretirement*** |  |
|  | ***Adjustment*** | ***Actuarial Items*** | ***Total*** |
| Balance at January 1, 2025 | $**(48915)** | $**18** | $**(48897)** |
| Other comprehensive income before reclassifications | **7363** |  | $**7363** |
| Amounts reclassified from accumulated other comprehensive income |  | **14** | $**14** |
| Balance at September 27, 2025 | $**(41552)** | $**32** | $**(41520)** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | ***Foreign*** | ***Pension*** |  |
|  | ***Currency*** | ***and Other*** |  |
|  | ***Translation*** | ***Postretirement*** |  |
|  | ***Adjustment*** | ***Actuarial Items*** | ***Total*** |
| Balance at January 1, 2024 | $(39262) | $393 | $(38869) |
| Other comprehensive loss before reclassifications | (679) |  | (679) |
| Amounts reclassified from accumulated other comprehensive loss |  | (16) | (16) |
| Balance at September 28, 2024 | $(39941) | $377 | $(39564) |

---

Reclassifications of pension and other postretirement actuarial items out of accumulated other comprehensive income (loss) are included in the computation of net periodic benefit cost (*see Note *9* - Pension and Other Postretirement Benefits*).

**<u>Note *9*</u>** <u>–</u> **<u>Pension and Other Postretirement Benefits</u>**

Employees of VPG participate in various defined benefit pension and other postretirement benefit ("OPEB") plans. The following table sets forth the components of the net periodic benefit cost for the Company's defined benefit pension and OPEB plans *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** |
|  | ***September 27, 2025*** | ***September 27, 2025*** | ***September 28, 2024*** | ***September 28, 2024*** |
|  | ***Pension*** | ***OPEB*** | ***Pension*** | ***OPEB*** |
|  | ***Plans*** | ***Plans*** | ***Plans*** | ***Plans*** |
| Net service cost | $**66** | $**3** | $66 | $4 |
| Interest cost | **208** | **28** | 191 | 27 |
| Expected return on plan assets | **(176)** |  | (211) |  |
| Amortization of actuarial losses (gains) | **2** | **(8)** | 4 | (3) |
| Net periodic benefit cost | $**100** | $**23** | $50 | $28 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 27, 2025*** | ***September 28, 2024*** | ***September 28, 2024*** |
|  | ***Pension*** | ***OPEB*** | ***Pension*** | ***OPEB*** |
|  | ***Plans*** | ***Plans*** | ***Plans*** | ***Plans*** |
| Net service cost | $**195** | $**10** | $199 | $12 |
| Interest cost | **613** | **85** | 572 | 81 |
| Expected return on plan assets | **(519)** |  | (630) |  |
| Amortization of actuarial losses (gains) | **7** | **(24)** | 13 | (9) |
| Net periodic benefit cost | $**296** | $**71** | $154 | $84 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *17*-

------

**<u>Note *10*</u>** <u>–</u> **<u>Share-Based Compensation</u>**

The Vishay Precision Group, Inc. *2022* Stock Incentive Plan (the *"2022* plan") permits issuance of up to 608,000 shares of common stock. At *September 27, 2025*, the Company had reserved 378,739 shares of common stock for future grants of equity awards (restricted stock, unrestricted stock, restricted stock units ("RSUs"), or stock options) pursuant to the *2022* plan. If any outstanding awards are forfeited by the holder or canceled by the Company, the underlying shares would be available for re-grant to others. If shares are withheld for payment of taxes, those shares do *not* become available for grant under the *2022* plan.

On *February 25, 2025* and in accordance with their respective employment agreements, VPG's *three* executive officers were granted annual equity awards in the form of RSUs, of which 50% are performance-based. The awards have an aggregate grant-date fair value of $1.9 million and were comprised of 79,729 RSUs. Fifty percent of these awards will vest on *January 1, 2028,* subject to the executives' continued employment. The performance-based portion of the RSUs will also vest on *January 1, 2028,* subject to the executives' continued employment and the satisfaction of certain performance objectives relating to *three*-year cumulative "adjusted free cash flow" and "net earnings goals", each weighted equally.

On *February 25, 2025,* certain non-executive VPG employees were granted annual equity awards in the form of RSUs. Certain employees received awards, of which 75% are performance-based and certain employees received awards of which 50% are performance-based. The awards have an aggregate grant-date fair value of $0.4 million and were comprised of 18,282 RSUs. The non-performance portion of these awards (twenty-five percent for certain employees and fifty percent for certain employees) will vest on *January 1, 2028,* subject to the employees' continued employment. The performance-based portion of the RSUs will also vest on *January 1, 2028,* subject to the employees' continued employment and the satisfaction of certain performance objectives relating to *three*-year cumulative earnings and cash flow goals, each weighted equally.

On *May 21, 2025,* and in accordance with the Company's *2025* Non-Employee Director Compensation Plan, the Board of Directors ("Board") approved the issuance of an aggregate of 18,252 RSUs to the independent board members of the Board.

The awards had an aggregate grant-date fair value of $0.5 million and will vest on or before the *2026* Annual Stockholders Meeting in *May 2026,* subject to each applicable director's continued service on the Board. Vesting of equity awards is subject to acceleration under certain circumstances.

On *July 1, 2025,* certain non-executive VPG employees were granted annual equity awards in the form of RSUs. One employee received an award, of which 75% is performance-based and *one* employee received an award of which 50% is performance-based. The awards have an aggregate grant-date fair value of $0.1 million and were comprised of 2,444 RSUs. The non-performance portion of these awards will vest on *July 1, 2028,* subject to the employees' continued employment. The performance-based portion of the RSUs will also vest on *July 1, 2028,* subject to the employees' continued employment and the satisfaction of certain performance objectives relating to *three*-year cumulative earnings and cash flow goals, each weighted equally.

The amount of compensation cost related to share-based payment transactions is measured based on the grant-date fair value of the equity instruments issued. VPG determines compensation cost for RSUs based on the grant-date fair value of the underlying common stock. The Company recognizes compensation cost for RSUs that are expected to vest and for which performance criteria are expected to be met. The following table summarizes share-based compensation expense recognized *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** | ***September 27, 2025*** | ***September 28, 2024*** |
| Share-based compensation expense | $**493** | $107 | $**1550** | $1060 |

---

**<u>Note *11*</u>**<u>–</u> **<u>Segment Information</u>**

VPG reports in three reporting segments: Sensors, Weighing Solutions, and Measurement Systems. The Sensors segment is comprised of the foil resistor and strain gage operating segments. The Weighing Solutions segment is comprised of specialized modules and systems used to precisely measure weight, force torque, and pressure. The Measurement Systems segment is comprised of highly specialized systems for steel production, materials development, and safety testing.

The chief operating decision maker ("CODM") is our chief executive officer. The evaluation of the segments' performance is based on multiple performance measures including revenues and operating income, exclusive of certain items. Management believes that evaluating segment performance, excluding items such as restructuring, severance, gain on asset held for sale, impairment of goodwill and indefinite-lived intangible assets and amortization of intangible assets, acquisition costs, and other items is meaningful because they relate to occurrences or events that are outside of our core operations, and management believes that the use of these measures provides a consistent basis to evaluate our operating profitability and performance trends across comparable periods.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *18*-

------

**<u>Note *11*</u>**<u>–</u> **<u>Segment Information (continued)</u>**

The following table sets forth reporting segment information *(in thousands)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***Sensors*** | ***Weighing Solutions*** | ***Measurement Systems*** | ***Corporate/ Other*** | ***Total*** |
| **<u>Three Fiscal Months Ended September 27, 2025</u>** |  |  |  |  |  |
| Net third-party revenues | $**31624** | $**27538** | $**20566** | $**—** | $**79728** |
| Intersegment revenues | **405** | **158** | **—** | **(563)** | **—** |
| Total revenues | **32029** | **27696** | **20566** | **(563)** | **79728** |
| Costs of products sold | **21403** | **16586** | **10177** | **(563)** | **47603** |
| Gross profit | **10626** | **11110** | **10389** |  | **32125** |
| Research and development expenses | **980** | **1305** | **2754** |  | **5039** |
| Segment selling, general, and administrative expenses <sup>(1)</sup> | **4152** | **4951** | **4555** |  | **13658** |
| Segment operating income | **5494** | **4854** | **3080** |  | **13428** |
| Other supplemental information: |  |  |  |  | *—* |
| Restructuring costs |  | **60** | **136** | **18** | **214** |
| Depreciation and amortization expense | **1594** | **781** | **1080** | **534** | **3989** |
| Capital expenditures | **1933** | **514** | **147** | **105** | **2699** |
| **<u>Three Fiscal Months Ended September 28, 2024</u>** |  |  |  |  |  |
| Net third-party revenues | $28201 | $25174 | $22352 | $— | $75727 |
| Intersegment revenues | 337 |  |  | (337) |  |
| Total revenues | 28538 | 25174 | 22352 | (337) | 75727 |
| Costs of products sold | 19808 | 16334 | 9662 | (337) | 45467 |
| Gross profit | 8730 | 8840 | 12690 |  | 30260 |
| Research and development expenses | 1136 | 1225 | 2536 |  | 4897 |
| Segment selling, general, and administrative expenses <sup>(1)</sup> | 3954 | 4770 | 5024 |  | 13748 |
| Segment operating income | 3640 | 2845 | 5130 |  | 11615 |
| <u>Other supplemental information:</u> |  |  |  |  |  |
| Restructuring costs | 59 | 23 |  |  | 82 |
| Depreciation and amortization expense | 1567 | 841 | 1076 | 429 | 3913 |
| Capital expenditures | 1353 | 399 | 347 | 69 | 2168 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | ***Sensors*** | ***Weighing Solutions*** | ***Measurement Systems*** | ***Corporate/ Other*** | ***Total*** |
| **<u>Nine Fiscal Months Ended September 27, 2025</u>** |  |  |  |  |  |
| Net third-party revenues | $**85243** | $**83404** | $**57983** | $**—** | $**226630** |
| Intersegment revenues | **1237** | **520** | **—** | **(1757)** |  |
| Total revenues | **86480** | **83924** | **57983** | **(1757)** | **226630** |
| Costs of products sold | **59220** | **51451** | **27952** | **(1757)** | **136866** |
| Gross profit | **27260** | **32473** | **30031** |  | **89764** |
| Research and development expenses | **3021** | **3941** | **8333** |  | **15295** |
| Segment selling, general, and administrative expenses <sup>(1)</sup> | **11609** | **14401** | **13594** |  | **39604** |
| Segment operating income | **12630** | **14131** | **8104** |  | **34865** |
| Other supplemental information: |  |  |  |  | *—* |
| Restructuring costs | **152** | **113** | **151** | **377** | **793** |
| Depreciation and amortization expense | **4791** | **2324** | **3228** | **1535** | **11878** |
| Capital expenditures | **3375** | **943** | **783** | **183** | **5284** |
| **<u>Nine Fiscal Months Ended September 28, 2024</u>** |  |  |  |  |  |
| Net third-party revenues | $86484 | $81466 | $65919 | $— | $233869 |
| Intersegment revenues | 1348 |  |  | (1348) |  |
| Total revenues | 87832 | 81466 | 65919 | (1348) | 233869 |
| Costs of products sold | 57303 | 51049 | 29104 | (1348) | 136108 |
| Gross profit | 30529 | 30417 | 36815 |  | 97761 |
| Research and development expenses | 3088 | 3973 | 7632 |  | 14693 |
| Segment selling, general, and administrative expenses <sup>(1)</sup> | 12178 | 14663 | 14113 |  | 40954 |
| Segment operating income | 15263 | 11781 | 15070 |  | 42114 |
| <u>Other supplemental information:</u> |  |  |  |  |  |
| Restructuring costs | 601 |  |  | 263 | 864 |
| Depreciation and amortization expense | 4753 | 2507 | 3217 | 1294 | 11771 |
| Capital expenditures | 3689 | 999 | 867 | 446 | 6001 |

---

<sup>(*1*)</sup> *Segment selling, general and administrative expenses are direct selling, general and administrative expenses, excluding research and development expenses and amortization of intangible assets attributed to the segment.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *19*-

------

**<u>Note *11*</u>**<u>–</u> **<u>Segment Information (continued)</u>**

The following table reconciles segment profit to consolidated income before taxes *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** | ***September 27, 2025*** | ***September 28, 2024*** |
| Segment operating income | $**13428** | $11615 | $**34865** | $42114 |
| Restructuring costs | $**214** | $82 | $**793** | $864 |
| Gain on asset held for sale | $**(5544)** | $— | $**(5544)** | $— |
| Unallocated G&A expenses | $**8599** | $7692 | $**26809** | $24585 |
| Operating income | $**10159** | $3841 | $**12807** | $16665 |
| Other expense | $**(266)** | $(3294) | $**(3306)** | $(1010) |
| Income before taxes | $**9893** | $546 | $**9501** | $15654 |

---

Products are transferred between segments on a basis intended to reflect, as nearly as practicable, the market value of the products. The table below summarizes intersegment sales *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***For the Nine Fiscal Months Ended*** | ***For the Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** | ***September 27, 2025*** | ***September 28, 2024*** |
| Sensors to Weighing Solutions | $**404** | $332 | $**1211** | $1323 |
| Sensors to Measurement Systems | **2** | 4 | **23** | 17 |

---

**<u>Note *12*</u>** <u>–</u> **<u>Earnings Per Share</u>**

The following table sets forth the computation of basic and diluted earnings per share attributable to VPG stockholders *(in thousands, except earnings per share)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***Nine Fiscal Months Ended*** | ***Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** | ***September 27, 2025*** | ***September 28, 2024*** |
| **Numerator:** |  |  |  |  |
| Numerator for basic earnings per share: |  |  |  |  |
| Net earnings (loss) attributable to VPG stockholders | $**7858** | $(1351) | $**7164** | $9143 |
| **Denominator:** |  |  |  |  |
| Denominator for basic earnings per share: |  |  |  |  |
| Weighted average shares | **13279** | 13254 | **13260** | 13367 |
| Effect of dilutive securities: |  |  |  |  |
| Restricted stock units | **65** |  | **47** | 38 |
| Dilutive potential common shares | **65** |  | **47** | 38 |
| Denominator for diluted earnings per share: |  |  |  |  |
| Adjusted weighted average shares | **13344** | 13254 | **13307** | 13405 |
| Basic earnings (loss) per share attributable to VPG stockholders | $**0.59** | $(0.10) | $**0.54** | $0.68 |
| Diluted earnings (loss) per share attributable to VPG stockholders | $**0.59** | $(0.10) | $**0.54** | $0.68 |

---

The Company's potentially dilutive securities were *not* included in the calculation of diluted loss per share for the *three* fiscal months ended *September 28, 2024*, as the effect would be anti-dilutive.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *20*-

------

**<u>Note *13*</u>** <u>–</u> **<u>Additional Financial Statement Information</u>**

*Other Income (Expense) Other*

The caption "Other" on the consolidated condensed statements of operations consists of the following *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Fiscal Quarter Ended*** | ***Fiscal Quarter Ended*** | ***For the Nine Fiscal Months Ended*** | ***For the Nine Fiscal Months Ended*** |
|  | ***September 27, 2025*** | ***September 28, 2024*** | ***September 27, 2025*** | ***September 28, 2024*** |
| Foreign currency exchange loss | $**(101)** | $(2912) | $**(2836)** | $(36) |
| Interest income | **489** | 370 | **1358** | 1192 |
| Pension expense | **(15)** | (8) | **(37)** | (28) |
| Other | **(214)** | (96) | **(266)** | (213) |
|  | $**159** | $(2646) | $**(1781)** | $915 |

---

Foreign currency exchange gain or loss is due to volatility in the global currency markets. For the *nine* fiscal months ended *September 27, 2025* the foreign currency exchange loss was largely due to the fluctuation of the Japanese yen, the Israeli Shekel and the British pound against the U.S. dollar.

*Other Accrued Expenses*

Other accrued expenses consist of the following *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | ***September 27, 2025*** | ***December 31, 2024*** |
| Customer advance payments | $**8893** | $7009 |
| Accrued restructuring | **114** | 235 |
| Goods received, not yet invoiced | **3652** | 1572 |
| Accrued taxes, other than income taxes | **1466** | 1994 |
| Accrued commissions | **3530** | 3895 |
| Accrued professional fees | **2198** | 1587 |
| Accrued technical warranty | **794** | 857 |
| Current accrued pensions and other post retirement costs | **596** | 596 |
| Other | **2916** | 1980 |
|  | $**24159** | $19725 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *21*-

------

**<u>Note *14*</u>** <u>–</u> **<u>Fair Value Measurements</u>**

ASC Topic *820, Fair Value Measurement,* establishes a valuation hierarchy of the inputs used to measure fair value. This hierarchy prioritizes the inputs to valuation techniques used to measure fair value into *three* broad levels. The following is a brief description of those *three* levels:

Level *1:* Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level *2:* Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are *not* active.

Level *3:* Unobservable inputs that reflect the Company's own assumptions.

An asset or liability's classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table provides the financial assets and liabilities carried at fair value measured on a recurring basis *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | ***Fair value measurements at reporting date using:*** | ***Fair value measurements at reporting date using:*** | ***Fair value measurements at reporting date using:*** |
|  | ***Total*** | ***Level 1*** | ***Level 2*** | ***Level 3*** |
|  | ***Fair Value*** | ***Inputs*** | ***Inputs*** | ***Inputs*** |
| **September 27, 2025** |  |  |  |  |
| Assets |  |  |  |  |
| Assets held in rabbi trusts | $**6462** | $**88** | $**6374** | $**—** |
| **December 31, 2024** |  |  |  |  |
| <u>Assets</u> |  |  |  |  |
| Assets held in rabbi trusts | $6228 | $45 | $6183 | $— |

---

The Company maintains non-qualified trusts, referred to as "rabbi" trusts, to fund payments under deferred compensation and non-qualified pension plans. Rabbi trust assets consist primarily of marketable securities, classified as available-for-sale money market funds at *September 27, 2025* and *December 31, 2024*, and company-owned life insurance assets. The marketable securities held in the rabbi trusts are valued using quoted market prices on the last business day of the period. The company-owned life insurance assets are valued in consultation with the Company's insurance brokers using the value of underlying assets of the insurance contracts. The fair value measurement of the cash equivalents held in the rabbi trust are considered a Level *1* measurement and the measurement of the company-owned life insurance assets is considered a Level *2* measurement within the fair value hierarchy.

The fair value of the long-term debt, excluding capitalized deferred financing costs, at *September 27, 2025* and *December 31, 2024* approximates its carrying value as the revolving debt is reset on a monthly basis based on current market rates, plus a base rate as specified in the debt agreement. The fair value of long-term debt is considered a Level *2* measurement within the fair value hierarchy. The Company's financial instruments include cash and cash equivalents, accounts receivable, short-term notes payable, and accounts payable. The carrying amounts for these financial instruments reported in the consolidated condensed balance sheets approximate their fair values.

**<u>Note *15*</u>** <u>–</u> **<u>Restructuring Costs</u>**

Restructuring costs primarily relate to cost reduction programs implemented by the Company. Restructuring costs are expensed during the period in which the Company determines it will incur those costs and all requirements for accrual are met. Because these costs are recorded based upon estimates, actual expenditures for the restructuring activities *may* differ from the initially recorded costs. If the initial estimates are too low or too high, the Company could be required either to record additional expense in future periods or to reverse part of the previously recorded charges.

The Company recorded $0.2 million and $0.1 million of restructuring costs during the fiscal quarter ended *September 27, 2025* and *September 28, 2024*, respectively, and $0.8 million and $0.9 million of restructuring costs during the *nine* fiscal months ended *September 27, 2025* and *September 28, 2024*, respectively. Restructuring costs were comprised primarily of employee termination costs, including severance and statutory retirement allowances, and were incurred in connection with various cost reduction programs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - *22*-

------

The following table summarizes recent activity related to all restructuring programs. The accrued restructuring liability balance as of *September 27, 2025* and *December 31, 2024*, respectively, is included in Other accrued expenses in the accompanying consolidated condensed balance sheets *(in thousands)*:

---

| | |
|:---|:---|
| Balance at December 31, 2024 | 235 |
| Restructuring charges in 2025 | 793 |
| Cash payments | (914) |
| Balance at September 27, 2025 | $114 |

---

**<u>Note *16*</u>** <u>–</u> **<u>Stockholder's Equity</u>**

On *August 8, 2022,* the Board of the Company authorized the repurchase of up to 600,000 shares of the Company's outstanding common stock (the "Stock Repurchase Plan"). The Stock Repurchase Plan was originally set to expire on *August 11, 2023.* On *August 8, 2023,* the Company announced that its Board extended the term of the previously approved stock repurchase plan to *August 9, 2024.* The stock repurchase plan expired in accordance with its terms on *August 9, 2024.* From *August 8, 2022* to *August 9, 2024,* the Company had repurchased an aggregate of 518,328 shares of its common stock under the stock repurchase plan for consideration of $16.5 million.

**<u>Note *17*</u>** <u>–</u> **<u>Commitments and Contingencies</u>**

***Tax Assessment***

During the *second* quarter of *2024,* the Israeli Tax Authority has issued a Value Added Tax (VAT) assessment to the Company, in the amount of ILS 8.4 million (approximately $2.5 million), pertaining to claims of VAT between the years *2019* to *2023.*

On *August 6, 2025,* the Company received the decision of the Israeli Tax Authority regarding the Company's appeal of the VAT assessment. The appeal was rejected, based on the same reasoning outlined in the original assessment issued to the Company.

The Company intends to appeal this decision and thereby defer the assessment in accordance with its rights under applicable law, and with the assistance of its legal counsel.

The Company believes that the liability for the assessment is *not* probable.

Given the stage of this matter, the Company is currently unable to predict the likely outcome or estimate the potential financial impact, if any, of this matter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -23-

------

**<u>Item 2.</u> <u>MANAGEMENT</u>**<u>'</u>**<u>S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</u>**

**Overview**

VPG is a global leader in precision measurement and sensing technologies that help power the future by bridging the physical world with the digital one. Many of our specialized sensors, weighing solutions, and measurement systems are "designed-in" by our customers, and address growing applications across a diverse array of industries and markets. Our products are marketed under brand names that we believe are characterized as having a very high level of precision and quality, and we employ an operationally diversified structure to manage our businesses.

Driven by the continued proliferation of data generated by the expanding use of sensors across a widening array of industrial and non-industrial applications, precision measurement and sensing technologies help ensure and deliver required levels of quality of mission-critical or high-value data. VPG's products are often at the first stage of a data value chain (i.e., the process of converting the physical world into a digital format that can be used for a specific purpose) and as such impact the effectiveness of vast number of critical, high-value downstream processes. Over the past few years, we have seen a broadening of precision sensing applications in both our traditional industrial markets and new markets, due to the development of higher functionality in our customers' end products. Our precision measurement solutions are used across a wide variety of end markets upon which we focus, including industrial, industrial automation and robotics, test and measurement, transportation, steel, medical, agriculture, avionics, military and space, and consumer product applications. The Company has a long heritage of innovation in sensor technologies that provide accuracy, reliability and repeatability that make our customers' products safer, smarter, and more productive. As the functionality of customers' products continues to increase, and they integrate more precision measurement sensors and related systems into their solutions, we believe this will offer substantial growth opportunities for our products and expertise.

**The impact of the recent wars in Israel on our operations**

In October 2023, Hamas terrorists infiltrated Israel's southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets, resulting in extensive casualties and military engagement. In addition, Hezbollah, another terrorist organization based in Lebanon, began attacking Israel. While Israel has entered into certain ceasefire agreements regarding the conflicts, the threat of new attacks remains, including from additional extremist groups.

On June 13, 2025, Israel launched a preemptive strike on Iran, with military support from the United States. Iran retaliated with ballistic missile and drone strikes targeting both civilian and military sites in Israel. A ceasefire between Israel and Iran was reached on June 23, 2025, although there is no assurance that the ceasefire will continue. Israel's airspace and maritime zones, which were closed to commercial traffic during the period between June 13 and June 23, 2025, are fully open as of November 4, 2025.

On October 12, 2025, the Government of Israel and Hamas reached a ceasefire agreement. The agreement, which was brokered with international mediation, led to a significant reduction in cross-border attacks and the reopening of commercial routes between Israel and the Gaza Strip.

While sales to customers in Israel account for a relatively small portion of our revenues, our operations in Israel include executive offices, which are the workplace for key executives including our chief executive officer, as well as two manufacturing facilities located in the central part of Israel that manufacture products representing approximately 30% of our total worldwide revenues in the nine fiscal months ended September 27, 2025. As of November 4, 2025, these facilities remain open and operational. We have implemented a contingency plan that, in the event conditions in Israel deteriorate such that we no longer operate there at normal levels, we believe will provide for securing supply of materials and logistics by producing a safety stock of finished goods and transferring these goods to our distribution centers outside of Israel, while continuing to take measures with regards to the safety of our employees. We may, however, determine to temporarily discontinue production in Israel for the safety of our employees. We could also face future production slowdowns or interruptions at either manufacturing location in Israel due to the impacts of the conflicts, including personnel absences as a number of our employees have been called to active military duty, or due to other resource constraints such as the inability to source materials for production.

**The impact of recent changes in tariffs**

We have manufacturing operations in India, China, Japan, Europe, Canada, Israel, and the United States, as well as in other countries.

Beginning in the second quarter of 2025, new tariffs were announced on import to the U.S. In response several countries have imposed reciprocal tariffs on import from the U.S. and other retaliatory measures. The tariffs have been set at various rates, with exemptions applicable to certain categories of imports and exports.

VPG continues to actively monitor and evaluate the ongoing situation, focusing on quickly responding to cost and price adjustments.

**Overview of Financial Results**

VPG reports in three product segments: Sensors, Weighing Solutions, and Measurement Systems. The Sensors segment is comprised of the foil resistor and strain gage operating segments. The Weighing Solutions segment is comprised of specialized modules and systems used to precisely measure weight, force torque, and pressure. The Measurement Systems segment is comprised of highly specialized systems for steel production, materials development, and safety testing.

Net revenues for the fiscal quarter ended September 27, 2025 were $79.7 million versus $75.7 million for the comparable prior year period. Net profit attributable to VPG stockholders for the fiscal quarter ended September 27, 2025 was $7.9 million, or $0.59 per diluted share, compared to net loss of $(1.4) million or $(0.10) per diluted share, for the comparable prior year period.

Net revenues for the nine fiscal months ended September 27, 2025 were $226.6 million versus $233.9 million for the comparable prior year period. Net earnings attributable to VPG stockholders for the nine fiscal months ended September 27, 2025 was $7.2 million, or $0.54 per diluted share, compared to net earnings of $9.1 million or $0.68 per diluted share, for the comparable prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -24-

------

The results of operations for the fiscal quarters ended September 27, 2025 and September 28, 2024 include items affecting comparability as listed in the reconciliations below. The reconciliations below include certain financial measures which are not recognized in accordance with U.S. generally accepted accounting principles ("GAAP"), including adjusted gross profits, adjusted gross profit margin, adjusted operating income, adjusted operating margin, adjusted net earnings, adjusted net earnings per diluted share, EBITDA, and adjusted EBITDA. These non-GAAP measures should not be viewed as an alternative to GAAP measures of performance. Non-GAAP measures such as adjusted gross profits, adjusted gross profit margin, adjusted operating income, adjusted operating margin, adjusted net earnings, adjusted net earnings per diluted share, EBITDA, and adjusted EBITDA do not have uniform definitions. These measures, as calculated by VPG, may not be comparable to similarly titled measures used by other companies. Management believes that these non-GAAP measures are useful to investors because each presents what management views as our core operating results for the relevant period. The adjustments to the applicable GAAP measures relate to occurrences or events that are outside of our core operations, and management believes that the use of these non-GAAP measures provides a consistent basis to evaluate our operating profitability and performance trends across comparable periods. In addition, the Company has historically provided these or similar non-GAAP measures and understands that some investors and financial analysts find this information helpful in analyzing the Company's performance and in comparing the Company's financial performance to that of its peer companies and competitors. Management believes that the Company's non-GAAP measures are regarded as supplemental to its GAAP financial results.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Gross Profit** | **Gross Profit** | **Operating Income** | **Operating Income** | **Net Earnings (loss) Attributable to VPG Stockholders** | **Net Earnings (loss) Attributable to VPG Stockholders** | **Diluted Earnings (loss) Per share** | **Diluted Earnings (loss) Per share** |
| **Three months ended** | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| As reported - GAAP | $**32125** | $30260 | $**10159** | $3841 | $**7858** | $(1351) | $**0.59** | $(0.10) |
| As reported - GAAP Margins | **40.3%** | 40.0% | **12.7%** | 5.1% |  |  |  |  |
| Start-up costs (a) | **37** |  | **37** |  | **37** |  | **0.00** |  |
| Acquisition purchase accounting adjustments (b) | **111** |  | **111** |  | **111** |  | **0.01** |  |
| Restructuring costs |  |  | **214** | 82 | **214** | 82 | **0.02** | 0.01 |
| Foreign currency exchange gain (c) |  |  |  |  | **101** | 2912 | **0.01** | 0.22 |
| Less: Gain on asset held for sale (d) |  |  | **5544** |  | **5544** |  | **0.42** |  |
| Less: Tax effect of reconciling items and discrete tax items |  |  |  |  | **(723**) | (839) | **(0.05**) | (0.06) |
| As Adjusted - Non GAAP | $**32273** | $30260 | $**4977** | $3923 | $**3500** | $2482 | $**0.26** | $0.19 |
| As Adjusted - Non GAAP Margins | **40.5%** | 40.0% | **6.2%** | 5.2% |  |  |  |  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Gross Profit** | **Gross Profit** | **Operating Income** | **Operating Income** | **Net Earnings Attributable to VPG Stockholders** | **Net Earnings Attributable to VPG Stockholders** | **Diluted Earnings Per share** | **Diluted Earnings Per share** |
| **Nine Fiscal Months Ended** | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| As reported - GAAP | $**89764** | $97761 | $**12806** | $16665 | $**7164** | $9143 | $**0.54** | $0.68 |
| As reported - GAAP Margins | **39.6%** | 41.8% | **5.7%** | 7.1% |  |  |  |  |
| Start-up costs (a) | **757** |  | **757** |  | **757** |  | $**0.06** |  |
| Acquisition purchase accounting adjustments (b) | **111** |  | **111** |  | **111** |  | $**0.01** |  |
| Restructuring costs |  |  | **793** | 864 | **793** | 864 | $**0.06** | 0.06 |
| Severance cost |  |  | **443** | 347 | **443** | 347 | $**0.03** | 0.03 |
| Foreign currency exchange gain (c) |  |  |  |  | **2836** | 34 | $**0.21** |  |
| Less: Gain on asset held for sale (d) |  |  | **5544** |  | **5544** |  | $**0.42** |  |
| Less: Tax effect of reconciling items and discrete tax items |  |  |  |  | **321** | (1913) | $**0.02** | (0.15) |
| As Adjusted - Non GAAP | $**90632** | $**97761** | $**9366** | $17876 | $**6239** | $12301 | $**0.47** | $0.92 |
| As Adjusted - Non GAAP Margins | **40.0%** | 41.8% | **4.1%** | 7.6% |  |  |  |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal Quarter Ended** | **Fiscal Quarter Ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Net earnings (loss) attributable to VPG stockholders | $**7858** | $(1351) | $**7164** | $9143 |
| Interest expense | **425** | 648 | **1525** | 1925 |
| Income tax expense | **1961** | 1874 | **2220** | 6508 |
| Depreciation | **3003** | 2988 | **8932** | 8996 |
| Amortization | **986** | 925 | **2946** | 2776 |
| Restructuring costs | **214** | 82 | **793** | 864 |
| Severance cost | **—** |  | **443** | 347 |
| Start-up costs (a) | **37** |  | **757** |  |
| Acquisition purchase accounting adjustments (b) | **111** |  | **111** |  |
| Foreign currency exchange gain (c) | **101** | 2912 | **2836** | 34 |
| Gain on asset held for sale (d) | **(5544)** |  | **(5544)** |  |
| **ADJUSTED EBITDA** | $**9152** | $8079 | $**22183** | $30594 |
| **ADJUSTED EBITDA MARGIN** | **11.5%** | 10.7% | **9.8%** | 13.1% |

---

(a) Start-up cost 2025

(b) Nokra GmbH acquisition which closed on September 30, 2024.

(c) Impact of foreign currency exchange rates on assets and liabilities.

(d) Gain on Sale of Manufacturing Facility in Kent, Washington.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -25-

------

**Financial Metrics**

We utilize several financial measures and metrics to evaluate performance and assess the future direction of our business. These key financial measures and metrics include net revenues, gross profit margin, end-of-period backlog, book-to-bill ratio, and inventory turnover.

Gross profit margin is computed as gross profit as a percentage of net revenues. Gross profit is generally net revenues less costs of products sold, but could also include certain other period costs. Gross profit margin is a function of net revenues, but also reflects our cost-cutting programs and our ability to contain fixed costs.

End-of-period backlog is one indicator of potential future sales. We include in our backlog only open orders that have been released by the customer for shipment in the next twelve months. If demand falls below customers' forecasts, or if customers do not control their inventory effectively, they may cancel or reschedule the shipments that are included in our backlog, in many instances without the payment of any penalty. Therefore, backlog is not necessarily indicative of the results expected for future periods.

Another important indicator of demand in our industry is the book-to-bill ratio, which is the ratio of the amount of product ordered during a period compared with the amount of product shipped during that period. A book-to-bill ratio that is greater than one indicates that revenues may increase in future periods. Conversely, a book-to-bill ratio that is less than one is an indicator of lower demand and may foretell declining sales. The book-to-bill ratio is also impacted by the timing of orders, particularly from our project-based product lines.

We focus on inventory turnover as a measure of how well we manage our inventory. We define inventory turnover for a financial reporting period as our costs of products sold for the four fiscal quarters ending on the last day of the reporting period divided by our average inventory (computed using each quarter-end balance) for this same period. A higher level of inventory turnover reflects more efficient use of our capital.

The quarter-to-quarter trends in these financial metrics can also be an important indicator of the likely direction of our business. The following tables show net revenues, gross profit margin, end-of-period backlog, book-to-bill ratio, and inventory turnover for our business as a whole and by segment during the five quarters beginning with the third quarter of 2024 through the third quarter of 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **3rd Quarter** | **4th Quarter** | **1st Quarter** | **2nd Quarter** | **3rd Quarter** |
| *(dollars in thousands)* | **2024** | **2024** | **2025** | **2025** | **2025** |
| Net revenues | $75727 | $72653 | $71741 | $75161 | $79728 |
| Gross profit margin | 40.0% | 38.2% | 37.7% | 40.7% | 40.3% |
| End-of-period backlog | $100191 | $96189 | $100300 | $108201 | $107624 |
| Book-to-bill ratio | 0.91 | 1.00 | 1.04 | 1.06 | 1.00 |
| Inventory turnover | 2.01 | 2.06 | 2.12 | 2.09 | 2.20 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **3rd Quarter** |  | **4th Quarter** |  | **1st Quarter** |  | **2nd Quarter** |  | **3rd Quarter** |  |
| *(dollars in thousands)* | **2024** |  | **2024** |  | **2025** |  | **2025** |  | **2025** |  |
| *<u>Sensors</u>* |  | |  | |  | |  | |  | |
| Net revenues | $28201 |  | $25755 |  | $27055 |  | $26563 |  | $31624 |  |
| Gross profit margin | 31 | % | 32 | % | 30.1 | % | 32 | % | 33.6 | % |
| End-of-period backlog | $39995 |  | $39605 |  | $42049 |  | $46661 |  | $48503 |  |
| Book-to-bill ratio | 0.89 |  | 1.04 |  | 1.06 |  | 1.12 |  | 1.07 |  |
| Inventory turnover | 2.28 |  | 2.15 |  | 2.38 |  | 2.27 |  | 2.66 |  |
| *<u>Weighing Solutions</u>* |  | |  | |  | |  | |  | |
| Net revenues | $25174 |  | $25739 |  | $26439 |  | $29428 |  | $27538 |  |
| Gross profit margin | 35.1 | % | 34.1 | % | 36.8 | % | 39.6 | % | 40.3 | % |
| End-of-period backlog | $25590 |  | $28003 |  | $28241 |  | $26734 |  | $23639 |  |
| Book-to-bill ratio | 1.00 |  | 1.12 |  | 0.99 |  | 0.92 |  | 0.89 |  |
| Inventory turnover | 2.10 |  | 2.35 |  | 2.50 |  | 2.62 |  | 2.25 |  |
| *<u>Measurement Systems</u>* |  | |  | |  | |  | |  | |
| Net revenues | $22352 |  | $21160 |  | $18247 |  | $19170 |  | $20566 |  |
| Gross profit margin | 56.8 | % | 50.9 | % | 50.3 | % | 54.6 | % | 50.5 | % |
| End-of-period backlog | $34605 |  | $28581 |  | $30010 |  | $34805 |  | $35482 |  |
| Book-to-bill ratio | 0.82 |  | 0.78 |  | 1.07 |  | 1.20 |  | 1.04 |  |
| Inventory turnover | 1.55 |  | 1.62 |  | 1.41 |  | 1.33 |  | 1.58 |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -26-

------

Net revenues for the third fiscal quarter of 2025 increased 6.1% from the second fiscal quarter of 2025 primarily due to increases in the Measurement Systems and Sensors reporting segments which were partially offset by a decrease in revenues in the Weighing Solutions reporting segment. Net revenues for the third fiscal quarter of 2025 increased 5.3% from the third fiscal quarter of 2024 due to increases in the Sensors and Weighing Solutions reporting segments which were partially offset by a decrease in revenues in the Measurement Systems reporting segment.

Net revenues in the Sensors reporting segment increased 19.1% compared to $26.6 million in the second fiscal quarter of 2025 and increased 12.1% from $28.2 million in the third fiscal quarter of 2024. The year-over-year increase in revenues was primarily attributable to higher sales of precision resistors and strain gages in the Test and Measurement and AMS markets. Sequentially, the increase primarily reflected higher sales of precision resistors in the Test and Measurement and AMS markets and higher sales of strain gages in the General Industrial market.

Net revenues in the Weighing Solutions reporting segment decreased 6.4% from the second fiscal quarter of 2025 and increased 9.4% from the third fiscal quarter of 2024. The year-over-year increase in revenues was mainly attributable to higher sales in the Transportation market. Sequentially, the decrease in revenues was primarily due to lower sales in the Transportation market and in Other Markets for OEM manufacturers of construction and precision agriculture equipment.

Net revenues in the Measurement Systems reporting segment increased 7.3% from the second fiscal quarter of 2025 and decreased 8.0% from the third fiscal quarter of 2024. The year-over-year decrease was primarily attributable to decreased revenue in the AMS market. Sequentially, the increase in revenue was primarily due to higher sales in the Steel Market, which offset lower sales to the AMS market.

Overall gross profit margin in the third fiscal quarter of 2025 decreased 0.4% as compared to the second fiscal quarter of 2025 due to Measurement Systems reporting segment and increased 0.3% from the third fiscal quarter of 2024 from the Sensors and Weighing Solutions reporting segments partially offset from Measurement system reporting segment.

**Optimize Core Competence**

The Company's core competencies include our innovative deep technical and applications-specific expertise to add value to our customers' products, our strong brands and customer relationships, our focus on operational excellence, our ability to select and develop our management teams, and our proven M&A strategy. We continue to optimize all aspects of our development, manufacturing and sales processes, including by increasing our technical sales efforts; continuing to innovate in product performance and design; and refining our manufacturing processes.

Our Sensors segment research group developed innovations that enhance the capability and performance of our strain gages, while simultaneously reducing their size and power consumption as part of our advanced sensors product line. We believe this unique foil technology will create new markets as customers "design in" these next generation products in existing and new applications. Our development engineering team is also responsible for creating new processes to further automate manufacturing and improve productivity and quality. Our advanced sensors manufacturing technology also offers us the capability to produce high-quality foil strain gages in a highly automated environment, which we believe results in reduced manufacturing and lead times, improved quality and increased margins. As a sign of our commitment to these businesses, we signed a long-term lease for a state-of-the-art facility that has been constructed in Israel.

Our design, research, and product development teams, in partnership with our marketing teams, drive our efforts to bring innovations to market. We intend to leverage our insights into customer demand to continually develop and roll out new, innovative products within our existing lines and to modify our existing core products in ways that make them more appealing, addressing changing customer needs and industry trends in terms of form, fit, and function.

We also seek to achieve significant production cost savings through the transfer, expansion, and construction of manufacturing operations in countries such as India, Japan, and Israel, where we can benefit from improved efficiencies or available tax and other government-sponsored incentives. In the past several years, we incurred restructuring expense related to closing and downsizing of facilities as part of the manufacturing transitions of our load cell products to facilities in India and China, which marked key milestones in our ongoing strategic initiatives to align and consolidate our manufacturing footprint.

**Acquisition Strategy**

We expect to continue to make strategic acquisitions where opportunities present themselves to grow and expand our segments. Historically, our growth and acquisition strategy had been largely focused on vertical product integration, using our foil strain gages in our load cell products, and incorporating those products into our weighing solutions. In recent years, we widened our acquisition strategy to include a broader set of precision measurement systems and product companies.

We expect to expand our expertise, and our acquisition focus, outside our traditional vertical approach to other precision measurement solutions, including in the fields of measurement of force, weight, pressure, torque, tilt, motion, and acceleration. We believe acquired businesses will benefit from improvements we implement to reduce redundant functions and from our current global manufacturing and distribution footprint. On September 30, 2024, the Company acquired Nokra Optische Prueftechnik und Automation GmbH, a Germany-based, privately held maker of precision measuring and testing equipment for manufacturing. Please see our Form 8-K dated September 30, 2024, for more information.

**Research and Development**

Research and development ("R&D") will continue to play a key role in our efforts to introduce innovative products to generate new sales and to improve profitability. We expect to continue to expand our position as a leading supplier of precision foil technology products. We believe our R&D efforts should provide us with a variety of opportunities to leverage technology, products, and our manufacturing base in order to ultimately improve our financial performance.

**Cost Management**

To be successful, we believe we must seek new strategies for controlling operating costs. Through automation in our plants, we believe we can optimize our capital and labor resources in production, inventory management, quality control, and warehousing. We are in the process of moving some manufacturing to more cost-effective locations. This may enable us to become more efficient and cost competitive and also maintain tighter controls of the operation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -27-

------

Production transfers, facility consolidations, and other long-term cost-cutting measures require us to initially incur significant severance and other exit costs. We are realizing the benefits of our restructuring through lower labor costs and other operating expenses and expect to continue reaping these benefits in future periods. However, these programs to improve our profitability also involve certain risks which could materially impact our future operating results, as further detailed in Part I, Item 1A "Risk Factors" of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February 25, 2025.

We are evaluating plans to further reduce our costs by consolidating additional manufacturing operations. These plans may require us to incur restructuring and severance costs in future periods. While streamlining and reducing fixed overhead, we are exercising caution so that we will not negatively impact our customer service or our ability to further develop products and processes.

**Goodwill**

We test the goodwill in each of our reporting units for impairment at least annually, as of the first day of our fourth quarter, and whenever events or changes in circumstances occur indicating that a possible impairment may have been incurred. Determining whether to test goodwill for impairment, and the application of goodwill impairment tests, require significant management judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value of each reporting unit. Changes in these estimates could materially affect the determination of fair value for each reporting unit. A slowdown or deferral of orders for a business, with which we have goodwill associated, could impact our valuation of that goodwill.

**Foreign Currency**

We are exposed to foreign currency exchange rate risks, particularly due to transactions in currencies other than the functional currencies of certain subsidiaries. U.S. GAAP requires that entities identify the "functional currency" of each of their subsidiaries and measure all elements of the financial statements in that functional currency. A subsidiary's functional currency is the currency of the primary economic environment in which it operates. In cases where a subsidiary is relatively self-contained within a particular country, the local currency is generally deemed to be the functional currency. However, a foreign subsidiary that is a direct and integral component or extension of the parent company's operations generally would have the parent company's currency as its functional currency. We have subsidiaries that fall into each of these categories.

***Foreign Subsidiaries which use the Local Currency as the Functional Currency***

Our operations in Europe, Canada, and certain locations in Asia primarily generate and expend cash using local currencies, and accordingly, these subsidiaries utilize the local currency as their functional currency. For those subsidiaries where the local currency is the functional currency, assets and liabilities in the consolidated condensed balance sheets have been translated at the rate of exchange as of the balance sheet date. Translation adjustments do not impact the results of operations and are reported as a separate component of equity.

For those subsidiaries where the local currency is the functional currency, revenues and expenses are translated at the average exchange rate for the period. While the translation of revenues and expenses into U.S. dollars does not directly impact the consolidated condensed statement of operations, the translation effectively increases or decreases the U.S. dollar equivalent of revenues generated and expenses incurred in those foreign currencies.

***Foreign Subsidiaries which use the U.S. Dollar as the Functional Currency***

Our operations in Israel and certain locations in Asia primarily generate cash in U.S. dollars, and accordingly, these subsidiaries utilize the U.S. dollar as their functional currency. For those foreign subsidiaries where the U.S. dollar is the functional currency, all foreign currency financial statement amounts are remeasured into U.S. dollars. Exchange gains and losses arising from remeasurement of foreign currency-denominated monetary assets and liabilities are included in the results of operations. While these subsidiaries transact most business in U.S. dollars, they may have significant costs, particularly related to payroll, which are incurred in the local currency and significant lease assets and liabilities.

***Effects of Foreign Currency Exchange Rate on Operations***

For the fiscal quarter ended September 27, 2025, the effect of foreign currency exchange rates increased net revenues by $1.2 million, and increased costs of products sold and selling, general, and administrative expenses by $2.6 million, when compared to the comparable prior year period.

For the nine fiscal months ended September 27, 2025, the effect of foreign currency exchange rates increased net revenues by $1.4 million, and increased costs of products sold and selling, general, and administrative expenses by $3.8 million, when compared to the comparable prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -28-

------

**Results of Operations**

Statement of operations' captions as a percentage of net revenues and the effective tax rates were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Costs of products sold | **59.7%** | 60.0**%** | **60.4%** | 58.2% |
| Gross profit | **40.3%** | 40.0**%** | **39.6%** | 41.8% |
| Selling, general, and administrative expenses | **34.2%** | 34.8**%** | **36.1%** | 34.3% |
| Operating income | **12.7%** | 5.1% | **5.7%** | 7.1% |
| Income before taxes | **12.4%** | 0.7% | **4.2%** | 6.7% |
| Net earnings (loss) | **9.9%** | (1.8)% | **3.2%** | 3.9% |
| Net earnings (loss) attributable to VPG stockholders | **9.9%** | (1.8)% | **3.2%** | 3.9% |
| Effective tax rate | **19.8%** | 343.2% | **23.4%** | 41.60% |

---

***Net Revenues***

Net revenues were as follows *(dollars in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Net revenues | $**79728** | $75727 | $**226630** | $233869 |
| Change versus comparable prior year period | $4001 |  | $(7239) |  |
| Percentage change versus prior year period | 5.3% |  | (3.1)% |  |

---

Changes in net revenues were attributable to the following:

---

| | | |
|:---|:---|:---|
|  | **vs. prior year** | **vs. prior year** |
|  | **quarter** | **to-date** |
| **Change attributable to:** |  |  |
| Change in volume | 1.6% | (4.4)% |
| Change in average selling prices | 1.9% | 0.8% |
| Foreign currency effects | 1.8% | 0.5% |
| Net change | 5.3% | (3.1)% |

---

During the fiscal quarter ended September 27, 2025 net revenues increased by 5.3%, as compared to the comparable prior year period, mainly due to higher volume on the Sensors and Weighing Solutions reporting segments. The year-over-year decreased by 3.1% in revenues was primarily attributable to lower volume on the Sensors and the Measurement Systems, partially offset by the Weighing Solutions reporting segment.

***Gross Profit Margin***

Gross profit as a percentage of net revenues was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Gross profit margin | **40.3%** | 40.0% | **39.6%** | 41.8% |

---

The gross profit margin for the fiscal quarter ended September 27, 2025, increased by 0.3% and for the nine fiscal months ended September 27, 2025 decreased 2.2% as compared to the comparable prior year periods. For the third fiscal quarter of 2025, Weighing Solutions and Sensors reporting segments had higher gross profit margins compared to the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -29-

------

***Segments***

Analysis of revenues and gross profit margins for each of our reportable segments is provided below.

*Sensors*

Net revenues of the Sensors segment were as follows *(dollars in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Net revenues | $**31624** | $28201 | $**85243** | $86484 |
| Change versus comparable prior year period | $**3423** |  | $(1241) |  |
| Percentage change versus prior year period | **12.1%** |  | (1.4)% |  |

---

Changes in Sensors segment net revenues were attributable to the following:

---

| | | |
|:---|:---|:---|
|  | **vs. prior year** | **vs. prior year** |
|  | **quarter** | **to-date** |
| **Change attributable to:** |  |  |
| Change in volume | **8.7%** | (2.2)% |
| Change in average selling prices | **1.3%** | 0.0% |
| Foreign currency effects | **2.1%** | 0.7% |
| Net change | **12.1%** | (1.4)% |

---

The Sensors segment revenue of $31.6 million in the third fiscal quarter of 2025 increased 12.1% from $28.2 million in the third fiscal quarter of 2024. The year-over-year increase in revenues was primarily attributable to higher sales of precision resistors and strain gages in the Test and Measurement and the AMS markets

The Sensors segment revenues of $85.2 million in the nine months ended September 27, 2025, decreased of 1.4 % from $86.5 million in the nine months ended September 28, 2024. The year-over-year decrease in revenues was primarily attributable to lower sales of strain gages in other markets partially offset by higher sales in the Test and Measurement market.

Gross profit as a percentage of net revenues for the Sensors segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Gross profit margin | **33.6%** | **31.0%** | **32.0%** | 35.3% |

---

Gross profit margin for the Sensors segment was 33.6% for the third fiscal quarter of 2025, as compared to 31.0% in the third fiscal quarter of 2024. The year-over-year increase in gross profit margin was primarily due to higher sales volume, partially offset by unfavorable foreign exchange rates

Gross profit margin for the nine months ended September 27, 2025, was 32.0% a decrease from 35.3% from the nine months ended September 28, 2024. The year-over-year decrease in gross profit margin relates to lower sales volume and unfavorable foreign exchange rates

*Weighing Solutions*

Net revenues of the Weighing Solutions segment were as follows *(dollars in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Net revenues | $**27538** | $25174 | $**83404** | $81466 |
| Change versus comparable prior year period | $**2364** |  | $1938 |  |
| Percentage change versus prior year period | **9.4%** |  | 2.4% |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -30-

------

Changes in Weighing Solutions segment net revenues were attributable to the following:

---

| | | |
|:---|:---|:---|
|  | **vs. prior year** | **vs. prior year** |
|  | **quarter** | **to-date** |
| **Change attributable to:** |  |  |
| Change in volume | **4.0%** | (0.1)% |
| Change in average selling prices | **2.4%** | 1.2% |
| Foreign currency effects | **3.0%** | 1.3% |
| Net change | **9.4%** | 2.4% |

---

The Weighing Solutions segment revenue of $27.5 million in the third fiscal quarter of 2025 increased 9.4% compared to $25.2 million in the third fiscal quarter of 2024. The year-over-year increase in revenues was mainly attributable to higher sales in the Transportation market.

The Weighing Solutions segment revenues of $83.4 million in the nine months ended September 27, 2025, an increase of 2.4% from 81.5 million in the nine months ended September 28, 2024. The year-over-year increase in revenues was mainly attributable to higher sales in the Transportation market.

Gross profit as a percentage of net revenues for the Weighing Solutions segment was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Gross profit margin | 40.3% | 35.1% | 38.9% | 37.3% |

---

Gross profit margin for the Weighing Solutions segment was 40.3% for the third fiscal quarter of 2025, which increased compared to 35.1% in the third fiscal quarter of 2024. The year-over-year increase in gross profit margin was primarily due to higher sales volume, favorable product mix and cost reductions.

Gross profit margin for the nine months ended September 27, 2025, was 38.9% as compared to 37.3% from the nine months ended September 28, 2024. The year-over-year increase in gross profit margin relates to favorable product mix and cost reductions.

*Measurement Systems*

Net revenues of the Measurement Systems segment were as follows *(dollars in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Net revenues | $**20566** | $22352 | $**57983** | $65919 |
| Change versus comparable prior year period | $**(1786)** |  | $(7936) |  |
| Percentage change versus prior year period | **(8.0)%** |  | (12.0)% |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -31-

------

Changes in Measurement Systems segment net revenues were attributable to the following:

---

| | | |
|:---|:---|:---|
|  | **vs. prior year** | **vs. prior year** |
|  | **quarter** | **to-date** |
| **Change attributable to:** |  |  |
| Change in volume | **(10.2)%** | (12.9)% |
| Change in average selling prices | **2.3%** | 1.4% |
| Foreign currency effects | **(0.1)%** | (0.5)% |
| Net change | **(8.0)%** | (12.0)% |

---

The Measurement Systems segment revenue of $20.6 million in the third fiscal quarter of 2025, a decrease of 8.0% year-over-year from $22.4 million in the third fiscal quarter of 2024. The year-over-year decrease was primarily attributable to decreased revenue in the AMS market.

The Measurement Systems segment revenues of $58.0 million in the nine months ended September 27, 2025, a decrease of 12.0% from $65.9 million in the nine months ended September 28, 2024. The year-over-year decrease was primarily attributable to decreased revenue in the Steel and AMS markets partially offset by higher sales in transportation.

Gross profit as a percentage of net revenues for the Measurement Systems segment were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal quarter ended** | **Fiscal quarter ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Gross profit margin | 50.5% | 56.8% | 51.8% | 55.8% |

---

Gross profit margin for the Measurement Systems segment was 50.5%, compared to 56.8% in the third fiscal quarter of 2024. The year-over-year decrease in gross profit margin was primarily due to lower sales volume and unfavorable product mix.

Gross profit margin for the nine months ended September 27, 2025, was 51.8% a decrease from 55.8% from the nine months ended September 28, 2024. The year-over-year decrease in gross profit margin relates to lower sales volume and favorable product mix.

**Selling, General, and Administrative Expenses**

Selling, general, and administrative ("SG&A") expenses are summarized as follows *(dollars in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Fiscal Quarter Ended** | **Fiscal Quarter Ended** | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |
|  | **September 27, 2025** | **September 28, 2024** | **September 27, 2025** | **September 28, 2024** |
| Total SG&A expenses | $**27296** | $26337 | $**81708** | $80232 |
| As a percentage of net revenues | **34.2%** | 34.8% | **36.1%** | 34.3% |

---

SG&A expenses for the fiscal quarter ended and nine fiscal months ended September 27, 2025 increased $1.0 million and $1.5 million respectively, compared to the comparable prior year period, mainly due to foreign exchange differences impact.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -32-

------

***Restructuring Costs***

Restructuring costs reflect the cost reduction programs implemented by the Company. Restructuring costs are expensed during the period in which the Company determines it will incur those costs and all requirements for accrual are met. Because these costs are recorded based upon estimates, actual expenditures for the restructuring activities may differ from the initially recorded costs. If the initial estimates are too low or too high, the Company could be required either to record additional expense in future periods or to reverse part of the previously recorded charges.

The Company recorded $0.2 million and $0.1 million of restructuring costs during the fiscal quarter ended September 27, 2025 and September 28, 2024, respectively, and $0.8 million and $0.9 million of restructuring costs during the nine fiscal months ended September 27, 2025 and September 28, 2024, respectively. Restructuring costs were comprised primarily of employee termination costs, including severance and statutory retirement allowances, in connection with various cost reduction programs.

***Other Income (Expense)***

The following table analyzes the components of the line "Other" on the consolidated condensed statements of operations *(in thousands)*:

---

| | | | |
|:---|:---|:---|:---|
|  | **Fiscal Quarter Ended** | **Fiscal Quarter Ended** |  |
|  | **September 27, 2025** | **September 28, 2024** | **Change** |
| Foreign currency exchange loss | $**(101)** | $(2912) | $2811 |
| Interest income | **489** | 370 | 119 |
| Pension expense | **(15)** | (8) | (7) |
| Other | **(214)** | (96) | (118) |
|  | $**159** | $(2646) | $2805 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **For the Nine Fiscal Months Ended** | **For the Nine Fiscal Months Ended** |  |
|  | **September 27, 2025** | **September 28, 2024** | **Change** |
| Foreign currency exchange loss | $**(2836)** | $(36) | $(2800) |
| Interest income | **1358** | 1192 | 166 |
| Pension expense | **(37)** | (28) | (9) |
| Other | **(266)** | (213) | (53) |
|  | $**(1781)** | $915 | $(2696) |

---

Foreign currency exchange gain or loss are due to volatility in the global currency markets. For the fiscal quarter ended September 27, 2025 the foreign currency exchange loss was largely due to the fluctuation of the Israeli Shekel against the U.S. dollar. For the nine fiscal months ended September 27, 2025 the foreign currency exchange loss was largely due to the fluctuation of the Japanese yen, Israeli Shekel and the British pound against the U.S. dollar.

***Income Taxes***

The Company reported an effective income tax rate of 19.8% for the third fiscal quarter of 2025, compared to 343.2% in the third fiscal quarter of 2024.

The effective tax rate for the fiscal quarter ended September 27, 2025, primarily resulted from an increase in U.S. taxable income, the impact of the One Big Beautiful Bill Act (the "OBBBA"), and changes in the valuation allowance on deferred tax assets, which provided a tax benefit.

Sequentially, the effective tax rate for the third quarter was mainly influenced by foreign income taxed at varying statutory rates and changes in the valuation allowance on deferred tax assets. For the nine fiscal months ended September 27, 2025, the Company reported an effective tax rate of 23.4%, compared to 41.6% for the same period in 2024.

The year-over-year change in the effective tax rate was primarily driven by a reduction in the valuation allowance on certain deferred tax assets and the impact of foreign currency exchange rate fluctuations on the tax provisions of our non-U.S. entities.

On July 4, 2025, the OBBBA was enacted into law, extending key provisions of the 2017 Tax Cuts and Jobs Act. The OBBBA restores expensing of domestic research expenditures for years beginning after December 31, 2024. Additionally, the OBBBA restores the EBITDA-based interest expense limitation and includes changes related to the U.S. taxation of the income of our foreign subsidiaries and certain foreign derived income, and the base erosion and anti-abuse tax, and provides for accelerated depreciation for property acquired and placed in service after January 19, 2025. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. Due to the OBBBA provisions, the Company recorded tax benefit for the quarter as a decrease in valuation allowance on part of our deferred tax assets.

The Company and its subsidiaries are subject to income taxes imposed by the U.S., various states, and the foreign jurisdictions in which we operate. Each jurisdiction establishes rules that set forth the years which are subject to examination by its tax authorities. While the Company believes the tax positions taken on its tax returns for each jurisdiction are supportable, they may still be challenged by the jurisdiction's tax authorities. In anticipation of such challenges, the Company has established reserves for tax-related uncertainties. These liabilities are based on the Company's best estimate of the potential tax exposures in each respective jurisdiction. It may take a number of years for a final tax liability in a jurisdiction to be determined, particularly in the event of an audit. If an uncertain matter is determined favorably, there could be a reduction in the Company's tax expense. An unfavorable determination could increase tax expense and could require a cash payment, including interest and penalties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -33-

------

**Financial Condition, Liquidity, and Capital Resources**

We believe that our current cash and cash equivalents, credit facilities and projected cash from operations will be sufficient to meet our liquidity needs for at least the next 12 months.

On August 15, 2024, the Company entered into a Fourth Amended and Restated Credit Agreement (the "2024 Credit Agreement") among the Company, the lenders party thereto, JPMorgan Chase Bank, N.A., Wells Fargo Bank, N.A. and HSBC as joint lead arrangers and joint bookrunner, and JPMorgan Chase Bank, N.A, as agent for such lenders, pursuant to which the 2020 Credit Agreement, as amended, was amended and restated to, among other things, extend the maturity date from March 20, 2025 to August 15, 2029 and adjust the interest rate and commitment fee. The 2024 Credit Agreement provides for a multi-currency, secured credit facility (the "2024 Revolving Facility") in an aggregate principal amount of $75.0 million, with a sublimit of $10.0 million which can be used for letters of credit for the account of the Company or its subsidiaries that are parties to the 2024 Credit Agreement, the proceeds of which may be used for working capital and general corporate purposes, and a portion of which were used to refinance the Company's previously existing credit agreement. The Company may elect to make loans under the 2024 Revolving Facility in US Dollars, Euros, Canadian Dollars, Sterling, Japanese Yen or such other freely convertible foreign currency.

On July 17, 2025, the Company made a partial repayment of its revolving debt in the amount of $11.0 million, using proceeds from the sale of manufacturing facility (see *Note 3 - Sale of *As*set Held for Sale*).

The repayment was made in accordance with the terms of the Credit Agreement and resulted in a corresponding reduction in the outstanding balance under the revolving credit facility. This repayment is expected to reduce annual interest expense by approximately $660,000. As of September 27, 2025, the outstanding balance under the revolving credit facility was $21.0 million, bearing interest at variable rates based on the Credit Agreement.

The obligations of the Company under the 2024 Credit Agreement are secured by pledges of stock in certain domestic and foreign subsidiaries, as well as guarantees by substantially all of the Company's domestic subsidiaries. The obligations of the Company and the guarantors under the 2024 Credit Agreement are secured by substantially all the assets (excluding real estate) of the Company and such guarantors. The 2024 Credit Agreement restricts the Company from paying cash dividends and requires the Company to comply with other customary covenants, representations, and warranties, including the maintenance of specific financial ratios. The financial maintenance covenants include an interest coverage ratio and a leverage ratio. The Company was in compliance with its financial maintenance covenants at September 27, 2025. If the Company is not in compliance with any of these covenant restrictions, the credit facility could be terminated by the lenders, and all amounts outstanding pursuant to the credit facility could become immediately payable.

Our business has historically generated significant cash flow. For the nine fiscal months ended September 27, 2025, cash provided by operating activities was $10.0 million compared to $13.0 million in the comparable prior year period. Our net cash used in investing activities for the nine fiscal months ended September 27, 2025 was higher compared to the prior year period mainly due to lower capital spending. Our net cash used in financing activities for the nine fiscal months ended September 27, 2025 was significantly higher when compared with the prior year period, due to the repayment on revolving facility in accordance with its terms on August 9, 2024.

Approximately 94% of our cash and cash equivalents balance at September 27, 2025 and December 31, 2024 were held by our non-U.S. subsidiaries.

See the following table for the percentage of cash and cash equivalents, by region, at September 27, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
|  | **September 27, 2025** | **December 31, 2024** |
| Israel | **31%** | 56% |
| Asia | **24%** | 21% |
| Europe | **32%** | 14% |
| United States | **6%** | 6% |
| Canada | **7%** | 3% |
|  | **100%** | **100%** |

---

We earn a significant amount of our operating income outside the United States, the majority of which is deemed to be indefinitely reinvested in foreign jurisdictions. As a result, as discussed above, a significant portion of our cash and short-term investments are held by foreign subsidiaries. The Company will continue to evaluate its cash needs, however we currently do not intend, nor do we foresee a need, to repatriate funds in excess of what is already planned. The Company will evaluate the possibility of repatriating future cash provided such repatriation can be accomplished in a tax efficient manner. In addition, we expect existing domestic cash, short-term investments, and cash flows from operations to continue to be sufficient to fund our domestic operating activities and cash commitments for investing and financing activities, such as debt repayment and capital expenditures, for at least the next 12 months and thereafter for the foreseeable future.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -34-

------

If we should require more capital in the United States than is generated by our domestic operations, for example, to fund significant discretionary activities, such as business acquisitions, we could elect to repatriate future earnings from foreign jurisdictions or raise capital in the United States through debt or equity issuances. These alternatives could result in higher tax expense, increased interest expense, or dilution of our earnings. We consider the majority of the undistributed earnings of our foreign subsidiaries, as of September 27, 2025, to be indefinitely reinvested.

Adjusted free cash flow generated during the nine fiscal months ended September 27, 2025, was $15.9 million. We refer to the amount of cash provided by operating activities ($10.0 million) in excess of our capital expenditures ($5.0 million), net of proceeds from the sale of assets ($10.9) million as "adjusted free cash flow."

The following table summarizes the components of net cash at September 27, 2025 and December 31, 2024 *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | **September 27, 2025** | **December 31, 2024** |
| Cash and cash equivalents | $**86253** | $79272 |
| Third-party long-term debt: |  |  |
| Revolving debt | **32000** | 32000 |
| Repayment of credit facility | **(11000)** |  |
| Deferred financing costs | **(445)** | (559) |
| Total third-party debt | **20555** | 31441 |
| Net cash | $**65698** | $47831 |

---

Measurements such as "adjusted free cash flow" and "net cash" do not have uniform definitions and are not recognized in accordance with U.S. GAAP. Such measures should not be viewed as alternatives to GAAP measures of performance or liquidity. However, management believes that "adjusted free cash flow" is a meaningful measure of our ability to fund acquisitions, and that an analysis of "net cash" assists investors in understanding aspects of our cash and debt management. These measures, as calculated by us, may not be comparable to similarly titled measures used by other companies.

Our financial condition as of September 27, 2025 remains strong, with a current ratio (current assets to current liabilities) of 4.1 to 1.0, as compared to a current ratio of 4.5 to 1.0 at December 31, 2024.

Cash paid for property and equipment for the nine fiscal months ended September 27, 2025 was $5.0 million compared to $7.0 million in the comparable prior year period.

As of September 27, 2025 and December 31, 2024, we did not have any off-balance sheet arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -35-

------

**Safe Harbor Statement**

From time to time, information provided by us, including, but not limited to, statements in this report, or other statements made by or on our behalf, may contain or constitute "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks, uncertainties, and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from those anticipated.

Such statements are based on current expectations only, and are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, expected, estimated, or projected. Among the factors that could cause actual results to materially differ include: general business and economic conditions; significant developments from the recent and potential changes in tariffs and trade regulation; impact of inflation; potential issues respecting the United States federal government debt ceiling; global labor and supply chain challenges; difficulties or delays in identifying, negotiating and completing acquisitions and integrating acquired companies; the inability to realize anticipated synergies and expansion possibilities; difficulties in new product development; changes in competition and technology in the markets that we serve and the mix of our products required to address these changes; changes in foreign currency exchange rates; political, economic, and health (including pandemics) instabilities; instability or disruption caused by military hostilities in the regions or countries in which we operate (including Israel); difficulties in implementing our cost reduction strategies, such as underutilization of production facilities, labor unrest or legal challenges to our lay-off or termination plans, operation of redundant facilities due to difficulties in transferring production to achieve efficiencies; compliance issues under applicable laws, such as export control laws, including the outcome of our voluntary self-disclosure of export control non-compliance; our ability to execute our new corporate strategy and business continuity, operational and budget plans; and other factors affecting our operations, markets, products, services, and prices that are set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. We caution you not to place undue reliance on forward-looking statements, which speak only as of the date of this report or as of the dates otherwise indicated in such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -36-

------

**<u>Item 3.</u> <u>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</u>**

There have been no material changes in the market risks previously disclosed in Part II, Item 7A "Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on February 25, 2025.

**<u>Item 4.</u> <u>CONTROLS AND PROCEDURES</u>**

**Disclosure Controls and Procedures** 

An evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Based on that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report to ensure that information required to be disclosed in reports that we file or submit under the Exchange Act are: (1) recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms; and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Our management, including our CEO and CFO, believes that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must consider the benefits of controls relative to their costs. Inherent limitations within a control system include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by unauthorized override of the control. While the design of any system of controls is to provide reasonable assurance of the effectiveness of disclosure controls, such design is also based in part upon certain assumptions about the likelihood of future events, and such assumptions, while reasonable, may not take into account all potential future conditions. Accordingly, because of the inherent limitations in a cost effective control system, misstatements due to error or fraud may occur and may not be prevented or detected.

**Changes in Internal Control over Financial Reporting**

During our last fiscal quarter ended September 27, 2025, there was no change in our internal control over financial reporting that materially affected, or is reasonable likely to materially affect, internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -37-

------

**PART II - OTHER INFORMATION**

**<u>Item 1.</u> <u>LEGAL PROCEEDINGS</u>**

The Company is subject to various legal proceedings that constitute ordinary, routine litigation incidental to its business. The Company believes that the foregoing matters will not have a material adverse effect on the Company's business or its financial condition, results of operations, and cash flows.

**<u>Item 1A.</u> <u>RISK FACTORS</u>**

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on February 25, 2025. There have been no material changes in reported risk factors from the information reported in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

**<u>Item 2.</u> <u>UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</u>**

None.

**<u>Item 3.</u> <u>DEFAULTS UPON SENIOR SECURITIES</u>**

None.

**<u>Item 4.</u> <u>MINE SAFETY DISCLOSURES</u>**

Not applicable.

**<u>Item *5.*</u> <u>OTHER INFORMATION</u>**

**Item *5.02* Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On *October 30, 2025,* the Board (i) appointed Rafi Ouzan, the Company's Senior Vice President, Division Head – Weighing Solutions, to serve as the Chief Operating Officer of the Company and (ii) appointed Yair Alcobi to serve as Chief Business and Product Officer of the Company, in each case effective *November 2, 2025.* Mr. Ouzan and Mr. Alcobi will each report to Ziv Shoshani, the Company's Chief Executive Officer.

Biographical and other information about Mr. Ouzan is included in the Company's Definitive Proxy Statement on Schedule *14A* filed with the U.S. Securities and Exchange Commission on *April 11, 2025.* Mr. Ouzan is entitled to receive a base salary of *1,046,000* New Israeli Shekels ("NIS"), an annual bonus of up to *50%* of his annual base salary and an annual equity award, with an aggregate value equal to *30%* of his annual base salary.

From *2024* until his appointment, Mr. Alcobi, *54,* had served as Chief Executive Officer of Highcon Systems Ltd., a company specializing in digital finishing solutions for the packaging industry. Prior to that role, he was the Chief Executive Officer of XJET Ltd., a *3D* printing company, from *2022* to *2024,* and Vice President of KLA Corporation, a Nasdaq-listed electronics equipment and services company, from *2019* to *2022.* Prior to his role at KLA Corporation, Mr. Alcobi held various positions at Orbotech (until Orbotech was acquired by KLA Corporation), Kulicke & Soffa Industries, Inc. and ISCAR Ltd.

Mr. Alcobi is entitled to receive a base salary of *1,248,000* NIS, an annual bonus of up to *50%* of his annual base salary and an annual equity award, with an aggregate value equal to *30%* of his annual base salary.

Neither Mr. Ouzan nor Mr. Alcobi has any family relationships with any director or executive officer of the Company, and there are no arrangements or understandings between either Mr. Ouzan or Mr. Alcobi and any other persons pursuant to which Mr. Ouzan or Mr. Alcobi was selected to his position. Neither Mr. Ouzan or Mr. Alcobi or any related person of Mr. Ouzan or Mr. Alcobi has a direct or indirect material interest in any existing or currently proposed transaction to which the Company is or *may* become a party that would require disclosure under Item *404*(a) of Regulation S-K promulgated under the Securities Exchange Act of *1934,* as amended.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -38-

------

**<u>Item 6.</u> <u>EXHIBITS</u>**

---

| | |
|:---|:---|
| 31.1 | [Certification pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 <u>– Ziv Shoshani, Chief Executive Officer.</u>](ex_854360.htm) |
| 31.2 | [Certification pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 <u>– William M. Clancy, Chief Financial Officer.</u>](ex_854361.htm) |
| 32.1 | [Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 <u>– Ziv Shoshani, Chief Executive Officer.</u>](ex_854362.htm) |
| 32.2 | [Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 <u>– William M. Clancy, Chief Financial Officer.</u>](ex_854363.htm) |
| 101 | Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended September 27, 2025, furnished in iXBRL (Inline eXtensible Business Reporting Language). |
| 104 | Cover Page Interactive Data File formatted as Inline XBRL and contained in Exhibit 101. |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -39-

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| |
|:---|
| VISHAY PRECISION GROUP, INC. |
| /s/ William M. Clancy |
| William M. Clancy |
| Executive Vice President and Chief Financial Officer |
| (as a duly authorized officer and principal financial and accounting officer) |

---

Date: November 4, 2025

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -40-

## Exhibit 31.1

Exhibit 31.1

**CERTIFICATIONS** 

I, Ziv Shoshani, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Vishay Precision Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: November 4, 2025 |
| /s/ Ziv Shoshani |
| Ziv Shoshani |
| President and Chief Executive Officer |

---

## Exhibit 31.2

Exhibit 31.2

**CERTIFICATIONS** 

I, William M. Clancy, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Vishay Precision Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: November 4, 2025 |
| /s/ William M. Clancy |
| William M. Clancy |
| Executive Vice President and Chief Financial Officer |

---

## Exhibit 32.1

Exhibit 32.1

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of Vishay Precision Group, Inc. (the "Company") on Form 10-Q for the fiscal quarter ended September 27, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ziv Shoshani, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Ziv Shoshani |
| Ziv Shoshani |
| President and Chief Executive Officer |
| November 4, 2025 |

---

## Exhibit 32.2

Exhibit 32.2

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of Vishay Precision Group, Inc. (the "Company") on Form 10-Q for the fiscal quarter ended September 27, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William M. Clancy, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ William M. Clancy |
| William M. Clancy |
| Executive Vice President and Chief Financial Officer |
| November 4, 2025 |

---